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Abstract Leishmania donovani causes visceral leishmaniasis (VL), the second most deadly vector-
borne parasitic disease. A recent epidemic in the Indian subcontinent (ISC) caused up to 80% of
global VL and over 30,000 deaths per year. Resistance against antimonial drugs has probably been
a contributing factor in the persistence of this epidemic. Here we use whole genome sequences
from 204 clinical isolates to track the evolution and epidemiology of L. donovani from the ISC. We
identify independent radiations that have emerged since a bottleneck coincident with 1960s DDT
spraying campaigns. A genetically distinct population frequently resistant to antimonials has a two
base-pair insertion in the aquaglyceroporin gene LdAQP1 that prevents the transport of trivalent
antimonials. We find evidence of genetic exchange between ISC populations, and show that the
mutation in LdAQP1 has spread by recombination. Our results reveal the complexity of L. donovani
evolution in the ISC in response to drug treatment.
DOI: 10.7554/eLife.12613.001
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Introduction
Parasites of the Leishmania donovani species complex cause visceral leishmaniasis (VL), the most
severe presentation of leishmaniasis that is usually fatal if untreated. There are probably between
200,000 and 300,000 VL cases annually (Alvar et al., 2012), leading to as many as 50,000 deaths per
year (den Boer et al., 2011; Lozano et al., 2012). VL is widespread in both the New and Old Worlds
(Pigott et al., 2014), but as much as 80% of the global VL burden occurs in the Indian sub-continent
(Alvar et al., 2012). Recent intensified control efforts have led to a notable decline in cases
(Chowdhury et al., 2014) but the problem is not yet eliminated. VL is a key neglected tropical dis-
ease, affecting the poorest regions of the world and the poorest communities within these regions
(Boelaert et al., 2009). VL was first reported in the Indian sub-continent (ISC) in the 1820s, but ini-
tially confused with malaria until the discovery of L. donovani in 1903 (Gibson, 1983). Although VL
was nearly eliminated from the ISC in the 1960s (Thakur, 2007) by antimalarial spraying campaigns
with DDT, it re-emerged in 1977 and has caused several subsequent major epidemics (Dye and Wol-
pert, 1988). Widespread chemotherapy for VL in the region has been ongoing since the 1820s, ini-
tially with quinine and other drugs, followed by extensive use of the trivalent antimonial SbIII (1915)
and compounds of the less toxic pentavalent SbV (1922) such as sodium stibogluconate (SSG), and
since 2005 with miltefosine (MIL) that is freely supplied through a government-subsidized control
program. The parasite developed resistance to both SbIII and SbV, and after ten years of clinical use
there has been a notable decline in MIL efficacy (Rijal et al., 2013; 2007; Sundar et al., 2012).
Leishmania parasites can re-shape their genome rapidly in vitro in response to stress
(Leprohon et al., 2009), suggesting structural variation is an important feature by which they can
eLife digest The parasite Leishmania donovani causes a disease called visceral leishmaniasis
that affects many of the world’s poorest people. Around half a million new cases develop every year,
but health authorities lack safe and effective drugs to treat them. Up to 80% of these cases occur in
the Indian subcontinent, where devastating epidemics have occurred in the last decades.
One reason these epidemics continue to occur is that the parasites develop genetic mutations
allowing them to adapt to and resist the drugs used to kill them. As there are few existing drugs
that can kill L. donovani, it is crucial to understand how drug resistance emerges and spreads among
parasite populations.
Imamura, Downing, Van den Broeck et al. have now investigated the history of visceral
leishmaniasis epidemics by characterising the complete genetic sequence – or genome – of 204 L.
donovani parasite samples. This revealed that the majority of parasites in the Indian subcontinent
first appeared in the nineteenth century, matching the first historical records of visceral leishmaniasis
epidemics.
The genomes show that most of the parasites are genetically similar and can be clustered into
several closely related groups. These groups first appeared in the 1960s following the end of a
regional campaign to eradicate malaria. The most common parasite group is particularly resistant to
drugs called antimonials, which were the main treatment for leishmaniasis until recently. These
parasites have a small genetic change that scrambles most of a protein known to be involved in the
uptake of antimonials.
Parasites may also be able to develop resistance to drugs through additional mechanisms that
allow them to produce many copies of the same gene. These mechanisms could allow the parasites
to rapidly adapt to new drugs or changes in the populations it infects. The work of Imamura et al.
looks only at parasites isolated from patients then grown in the laboratory, so further research is
now needed to explore how variable the Leishmania genome is in both of the parasite’s hosts:
humans and sandflies.
Imamura et al.’s study reveals how L. donovani has spread throughout the Indian subcontinent in
fine detail. The genome data can be used to create simple molecular tools that could form an "early
warning system" to track the success of disease control programs and to determine how well the
current drugs are working.
DOI: 10.7554/eLife.12613.002
Imamura et al. eLife 2016;5:e12613. DOI: 10.7554/eLife.12613 2 of 39
Research article Epidemiology and global health Microbiology and infectious disease
rapidly adapt to changing environmental conditions and drug pressure. However, there is little data
on the diversity of clinical Leishmania populations or how they evolve during treatment. While an
extensive literature has made use of molecular methods to study the population genetics of Leish-
mania (e.g. Alam et al., 2009; Lukes et al., 2007; Mauricio et al., 2006; Schonian et al., 2008),
existing genetic markers have relatively poor resolution, and in particular L. donovani within the ISC
show very little genetic differentiation based on these approaches (Alam et al., 2009;
Downing et al., 2012). Whole-genome sequence data has the potential to show significant popula-
tion structure within the ISC, and also allows us to identify changes in genome structure.
Here we report the genome sequences of 204 L. donovani isolates (Figure 1, Supplementary file
1), obtained from VL patients between 2002 and 2011 from regions in Nepal (N=98), India (N=98)
and Bangladesh (N=8) that represent the epicentre of the on-going VL epidemic in the ISC
(Figure 1a).
Results
Calling variants against a reference genome assembly for a Nepalese L. donovani strain (BPK282/
0cl4; Figure 2—figure supplement 1), we identify three divergent genetic lineages circulating in
this region (Figure 2b): a core group of 191 closely related parasites found in the highly endemic
Figure 1. History and geography of Indian subcontinent L. donovani. (a) Location of the patients from which the 204 L. donovani genomes were
isolated, and of historical Kala-Azar outbreaks. Genetic groups of the parasite isolates are indicated by the colour of the dots representing them,
matching those in Figure 2a,c. Sampling dates and locations are summarised in Figure 1—figure supplement 1, and detailed information about each
strain including GPS coordinates are given in the source data file. Citations are to historical primary literature reviewed and cited in (Gibson, 1983).
Posterior probability distributions of estimated ages for the oldest split in (b) the main population in Bihar and Nepal and (c) the ISC5 group associated
with Sb resistance. Dark shading shows estimates under a strict molecular clock, light shading from relaxed molecular clock and lines show relaxed
clock results with Bangladeshi and putative hybrid isolates included. (d) Estimated effective population size through time for ISC5 population (green)
and the rest of the parasite population (black/grey). Lines show median of posterior distributions, dark and light shading cover 50% and 95% of the
posterior density respectively. Dates for all splits on this phylogeny and other results of phylogeographic analysis are shown in Figure 1—figure
supplement 2.
DOI: 10.7554/eLife.12613.003
The following figure supplements are available for figure 1:
Figure supplement 1. Sampling of genetic groups.
DOI: 10.7554/eLife.12613.004
Figure supplement 2. Full results of discrete-space, constant population size molecular clock Bayesian phylogeography analysis of core population.
DOI: 10.7554/eLife.12613.005
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lowlands of all three countries, a small population of 12 Nepalese isolates found most frequently in
the highlands (ISC1) and a single divergent Nepalese isolate (BPK512/0cl9) (Downing et al., 2011).
These two main groups show fixed differences at 45,743 sites (Supplementary file 2, table a), and
two previously sequenced Sri Lankan L. donovani isolates (Zhang et al., 2014) were more closely
related to the core population (21,546 fixed differences) than to ISC1 (45,743 fixed differences). Par-
asites within each group show little SNP variation with only 5,628 variable sites in ISC1 and just
2,418 sites varying within the core population (Supplementary file 2, table b) and correspondingly
few SNPs in protein-coding regions (Supplementary file 2, table c). Core population isolates differ
at an average of 88.3 nucleotide sites with an average nucleotide diversity of 9.7 per Mb
(Supplementary file 2, table d).
Figure 2. Genealogical history of L. donovani from the ISC. (a) Maximum-likelihood tree based on SNPs called for 191 strains (see Figure 2—figure
supplement 1) from the core population in the Indian subcontinent. Samples are coloured by population assignment, with putative hybrid strains not
clustered in the main groups in black. Further analysis confirms the hybrid ancestry of some of these isolates (Figure 2—figure supplement 2). (b)
Unrooted phylogenetic network of the L. donovani complex based on split decomposition of maximum-likelihood distances between isolates described
here, reference genome isolates and two published Sri Lankan isolates (Zhang et al., 2014). (c) Model-based clustering of 191 isolates from the core
population reveals six discrete monophyletic groups, and some groups and other samples of less certain ancestry. Coloured bars show the fraction of
ancestry per strain assigned to a given cluster, with colours assigned to the population most closely related to each cluster. More detailed population
clustering analysis shows largely congruent results (Figure 2—figure supplements 3 and 4).
DOI: 10.7554/eLife.12613.006
The following figure supplements are available for figure 2:
Figure supplement 1. Flowchart of SNP detection using COCALL.
DOI: 10.7554/eLife.12613.007
Figure supplement 2. Haplotype networks for core population isolates.
DOI: 10.7554/eLife.12613.008
Figure supplement 3. Haplotype similarity for core population isolates.
DOI: 10.7554/eLife.12613.009
Figure supplement 4. Mosaic ancestry patterns in eight putative hybrid L. donovani isolates.
DOI: 10.7554/eLife.12613.010
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While a panel of microsatellite markers shows no variation between isolates from the core popula-
tion (Downing et al., 2012), we reveal significant spatial and temporal genetic structure within this
group despite this extremely low level of overall diversity (Figure 2a,c; Supplementary file 2, table
e). Phylogenetic and clustering methods identify six congruent monophyletic groups (ISC2-7). Three
other groups (ISC8-10) and 21 ungrouped isolates had more complex and less certain evolutionary
histories (Figure 2a,c; Supplementary file 2, table f). Most of the ISC groups are present through-
out our sampling window (2002–2011), and many are present in both India and Nepal (Figure 1—
figure supplement 1). There are some exceptions: ISC7 represents a recent radiation (first observed
in 2006) with almost no diversity (20 unique SNPs; Supplementary file 2, table g; p=1.8 per Mb)
and is restricted to India, while ISC6 is an older and more diverse group restricted to Nepal (p=12.2
per Mb). We observe subsequent evolution within some groups: ISC5 is distinguished from other
groups by just 32 SNP sites (Supplementary file 2, table h), but contains a subgroup with multiple
novel SNPs and lower somy (Supplementary file 2, table i).
Bayesian phylogenetic models in an explicit temporal and spatial framework revealed that the
core population diverged in the mid 19th century (Figure 1b), matching the dates of the earliest
reports of large-scale VL outbreaks in the ISC (Gibson, 1983) and thus suggesting that modern low-
land parasites descend from these early epidemics. Within the core population, the Indo-Nepalese
population itself appeared around 1900 (Figure 1—figure supplement 2), almost certainly in India
(0.89 posterior probability), matching the dates of the first reported outbreaks in Bihar (Gib-
son, 1983), more precisely in Purnea (Figure 2d). Most subsequent diversification is more recent,
with many groups (ISC2 & ISC4-6) radiating from the 1960s (Figure 1b), coinciding with the end of
the DDT spraying campaign. The estimated rate of migration from India to Nepal in the Core 191
group was significantly greater than that from Nepal to India, suggesting that India acts as a source
population seeding the Nepalese epidemic (Figure 1—figure supplement 2).
A lack of linkage disequilibrium decay between SNP pairs with genomic distance in the core pop-
ulation (r2~0.33 at 5–1,400 kb) reflects a lack of detectable recombination within the six main genetic
groups (ISC2-7) across the entire genome (Supplementary file 2, table j). While the low number of
SNPs varying within the core population limits our power to detect recombination, we find compel-
ling evidence of hybridisation among eight of the samples not assigned to any of the ISC groups
(Figure 2—figure supplements 2–4). The identity of these isolates as hybrids and our assignment of
other isolates to groups is supported by allele-frequency based methods (f-statistics), which should
be robust to gene flow between groups (Supplementary file 2, tables e,f) and population structure
analysis based on haplotype sharing (Supplementary files 2, tables k–n). The four-allele test also
confirms that recombination is largely restricted to these hybrids (Supplementary file 2, table o).
These isolates appear to result from multiple independent recent hybridizations between distinct
ancestors of either ISC5 and ISC6, ISC5 and ISC7, or ISC6 and ISC7 (Figure 2—figure supplement
2).
We detect extensive variation in the structure of these L. donovani genomes. Local copy-number
variants (CNVs) cover ~11% of the genome. These include sporadic gene duplication, dynamic tan-
dem gene array sizes (Figure 3—figure supplement 1) and long sub-telomeric amplifications/dele-
tions, the latter generally spanning whole transcription units. While structural variation in Leishmania
is often considered a transient adaptation, particularly to culture conditions in vitro, we find striking
conservation of many CNVs across all core population groups here. Two multigenic intra-chromo-
somal duplicated regions (MAPK1 and H-locus; Downing et al., 2011) are present in variable num-
bers in all core population isolates but are absent in ISC1 (Figure 3b,c; Figure 3—figure
supplement 2). Conserved heterozygous SNPs in both of these structural variants confirm that these
regions have duplicated once and been maintained throughout the evolution of this population. All
known genes on these duplicated regions are associated with virulence (MAPK1, ASS, sAcP;
Fernandes et al., 2013; Lakhal-Naouar et al., 2012; Wiese, 1998) or drug resistance
(Brotherton et al., 2013), indicating that extensive structural variation allows these parasites to alter
local copy number in response to changing environments: both aneuploidy and CNV regulate gene
expression (Leprohon et al., 2009). Most isolates are aneuploid (Figure 3—figure supplement 3),
even excluding the generally tetrasomic chromosome 31, and almost all chromosomes show some
variation in somy (Figure 3a). Aneuploidy (r2=0.15, p=2.7x10-118), CNVs (r2=0.26, p=7.5x10-218) and
indels (r2=0.30, p=2.1x10-254) are significantly correlated with SNP variation in the core isolates, sug-
gesting that these variants have appeared gradually during the evolution of the population in the
Imamura et al. eLife 2016;5:e12613. DOI: 10.7554/eLife.12613 5 of 39
Research article Epidemiology and global health Microbiology and infectious disease
field. Most strikingly, we find two cases of recent epidemic expansions associated with major
changes in aneuploidy and heterozygosity (Figure 4). Variation in somy can thus lead to changes in
heterozygosity, which could allow selection to eradicate recessive deleterious mutations in the
absence of recombination (Roze and Michod, 2010).
We find no statistically significant association between any individual SNP or structural genetic
variant and in vitro SSG resistance, or SSG or MIL treatment outcomes (Supplementary file 2, tables
p–r), but the distribution of antimony susceptibility was uneven across different ISC populations
(Supplementary file 1). 9 of 11 ISC5 samples tested were highly SbV-resistant and two out of four
ISC5-ISC6/7 hybrids tested have intermediate levels of resistance. One variant – a two-bp insertion
introducing a frameshift and premature stop codon in the aquaglyceroporin-1 gene (LdBPK_310030,
AQP1) – is homozygous in all 52 ISC5 isolates (Table 1), and heterozygous in six hybrids between
ISC5 and either ISC6 or ISC7. ISC5 isolates also share other genomic features – such as higher copy
number of both the H-locus and MAPK1 amplicons (Figure 3b,c). The H-locus includes MRPA, a
gene involved in the efflux of SbIII and associated with drug resistance (Leprohon et al., 2009).
Other lines of evidence strongly link AQP1 with antimony resistance. While recent antimonial drugs
such as SSG are compounds of pentavalent antimony (SbV), SbV is thought to act mostly as a pro-
drug, being reduced to SbIII in both the macrophage phagolysosome (Fre´zard et al., 2001) and in
the parasite itself (Denton et al., 2004; Decuypere et al., 2012). AQP1 is known to assist with SbIII
uptake, both genetic and transcriptional changes at this locus have been associated with Sb
Figure 3. Structural variations in ISC L. donovani. (a) Stacked barplots per chromosome showing the proportion of ISC strains that are monosomic,
disomic, trisomic, tretrasomic or pentasomic for the respective chromosome. A full breakdown of somy per strain is presented in Figure 3—figure
supplement 3, and a complete catalogue of other structural variants in Figure 3—figure supplement 1. Violin plots showing the copy number of
MAPK1 (b) and H-locus (c) per ISC group, except for ISC1 where these amplicons were absent. These amplicons are intra-chromosomal (Figure 3—
figure supplement 2). (d) Tetrameric protein model of the transport protein aquaglyceroporin-1. The C-terminus part that is affected by the 2-
nucleotide frameshift found in all ISC5 isolates is shown in magenta. Image was created using PyMOL version 1.50.04 (Schro¨dinger).
DOI: 10.7554/eLife.12613.011
The following figure supplements are available for figure 3:
Figure supplement 1. Copy number variants in all 206 genomes.
DOI: 10.7554/eLife.12613.012
Figure supplement 2. Copy number variation by intrachromosomal tandem duplication or extrachromosomal linear amplification in clinical isolate.
DOI: 10.7554/eLife.12613.013
Figure supplement 3. Chromosome number variation in L. donovani in the ISC.
DOI: 10.7554/eLife.12613.014
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resistance (Gourbal et al., 2004; Monte-Neto et al., 2015; Mukherjee et al., 2013;
Uzcategui et al., 2008) and a homologous transporter is associated with drug resistance in trypano-
somes (Baker et al., 2012). Recently, an AQP1 knockout line of Leishmania major was shown to be
resistant to SbIII due to reduced uptake (Plourde et al., 2015). The truncated frameshift protein
found in ISC5 is predicted to be incapable of forming a functional trans-membrane channel
(Figure 3d). We find three other independent frameshifts in AQP1 gene in other antimony resistant
isolates, including one in BPK181/12 (ISC6), an isolate taken from a patient following failure of ten
months of antimony treatment that was absent in the pre-treatment isolate from the same patient
(BPK181/ 0cl11, Table 1).
We propose that the AQP1 truncation is associated with antimonial resistance in the ancestor of
ISC5, and has been transmitted to a group of hybrid parasites. The ISC5 lineage emerged following
the end of the DDT campaigns but then proliferated quickly in the 1970s (Figure 1c,d), when anti-
monial dosage had to be doubled because of its declining efficacy. The persistence of this lineage
beyond the era of Sb treatment perhaps reflects the increased fitness (Vanaerschot et al., 2013) of
Sb-resistant parasites. These observations tally with a stronger signature of purifying selection on
the ISC5 lineage, measured as a lower rate of derived allele accumulation compared to other ISC
populations, which may be a consequence of higher historical exposure to drug stress
(Supplementary file 2, table s). Sb resistance is also present in other genetic groups, with 4 out of
15 ISC4 lines tested in vitro being SbV-R, indicating resistance has emerged independently and
recently multiple times in ISC L. donovani, and that other genetic variants responsible for SbV resis-
tance must be present in this population. Indeed, other SbV resistance mechanisms are known in this
population: previous work has shown that two resistant strains from ISC4 (BPK087 and BPK190)
show significantly decreased transcription of an AQP1 locus encoding a wildtype protein sequence
Figure 4. SNP heterozygosity and somy variation in two subclades. Two subclades show an expansion of polysomic strains from disomic ancestors
(below) and an expansion of disomic strains from polysomic ancestors (above). Somy variation per chromosome (1–36; above heatmap) and the total
number of heterozygote SNPs (right to heatmap) are shown for each individual strain.
DOI: 10.7554/eLife.12613.015
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(Decuypere et al., 2005), and BHU764 combines a different indel mutation in AQP1 and reduced
expression of MRPA, an efflux transporter of SbIII (Mukhopadhyay et al., 2011). The failure of any
single resistance locus to sweep through this population may reflect the low level of gene flow and
the presence of a large reservoir of untreated asymptomatic cases (Ostyn et al., 2011).
Discussion
We have shown that genomic data can retrospectively unravel the evolution and epidemiology of
this parasite population, and gain new insight into possible mechanisms of drug resistance against a
background of extensive variation in genome structure. We report the first analysis of the structure
and history of a Leishmania population, aligned with clinical and epidemiological records, enabled
by the higher resolution of genome sequence data than other genotyping approaches. These data
have allowed us to describe a mechanism of resistance to one of the most ancient drugs used in the
Table 1. Small indels. The first half of the table summarises the numbers and types of indels detected in each group. The second half
of the table shows the proportion of samples within a cluster that share each group-specific coding-region indel.
1. Number of indels ISC002 ISC003 ISC004 ISC005 ISC006 ISC007 ISC008 ISC009 ISC010
Total number ofindels found within each group 58 60 73 79 65 55 55 84 60
Number of group-specific Indels shared by part of the strains
of that group
9 5 11 12 7 0 8 22 7
Number of group-specific Indels shared by all the strains of
that group
6 1 3 3 0 0 0 0 2
Number of group-specific Indels within coding regions 0 1 2 3 4 0 1 3 1
2. Indels within coding region
Gene ID Gene product Position Type
LdBPK_310030 Aquaglyceroporin Ld31_0007774 2 0.04
LdBPK_310030 Aquaglyceroporin Ld31_0007735 2 1
LdBPK_310030 Aquaglyceroporin Ld31_0007662 1 0.04
LdBPK_310030 Aquaglyceroporin Ld31_0008099 2 0.11
LdBPK_291860 Putative historie H2A Ld29_0816454 -2 0.25
LdBPK_040410 Conserved hypothetical
protein
Ld04_0155491 3 0.08
LdBPK_070540 Conserved hypothetical
protein
Ld07_0230487 -3 0.12
LdBPK_190080 Conserved hypothetical
protein
Ldl9_0015151 1 0.04
LdBPK_261790 Conserved hypothetical
protein
Ld26_0651748 4 0.11
LdBPK_301000 Conserved hypothetical
protein
Ld30_0311376 -1 0.02
LdBPK_310690 Conserved hypothetical
protein
Ld31_0241951 -3 0.11
LdBPK_332580 Conserved hypothetical
protein
Ld33_0995960 1 0.04
LdBPK_366590 Conserved hypothetical
protein
Ld36_2473775 -3 0.25
LdBPK_110650 hypothetical, unknown
function
Ldll_0245832 -3 0.56
LdBPK_292330 hypothetical, unknown
function
Ld29_1008496 -3 0.08
DOI: 10.7554/eLife.12613.016
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human pharmacopeia, antimonials, not only identifying a key locus, but also showing the epidemio-
logical dynamics of a population carrying a loss-of-function variant at this locus.
Continued genetic surveillance of parasite populations is key to rapidly identify and respond to
the emergence of treatment failure. In the recent emergence of artemisinin resistance in Plasmodium
falciparum, genomic data has led to the identification of the major locus underlying resistance
(Ariey et al., 2014; Cheeseman et al., 2012), revealed the genetic architecture of resistance
(Miotto et al., 2015) and shed light on the population genetic context in which resistance is appear-
ing (Miotto et al., 2013). Genomic surveillance is playing a key role in defining the geographic
boundaries of the spreading artemisinin-resistant population. Failure of anti-Leishmania chemother-
apy could become a similar public health emergency: miltefosine has shown reduced efficacy in both
India (Sundar et al., 2012) and Nepal (Rijal et al., 2013). While amphotericin B is now being used
against visceral leishmaniasis in ISC, few alternative treatments are available, and continued genomic
surveillance will facilitate tracking the response of the Leishmania population to continued use of
these drugs.
Monitoring drug resistance in clinical settings is challenging: the data set we present was gener-
ated as part of a five-year collaboration between clinicians in the endemic countries, parasitologists
and genome biologists. This collaboration is critical in generating data that reflects the evolution of
parasite populations in close to real time and as such is directly applicable in a public health context.
The data we present here provide baseline information on the diversity of Leishmania donovani in
the ISC that will contribute to future studies of drug resistance and epidemiology of this population.
Our results show the promise of genomic surveillance for other Leishmania populations, where
patient symptoms, the parasites involved and the main treatment modalities all differ from those in
the ISC (Sundar and Chakravarty, 2015).
Materials and methods
Sample collection
The ethics committee of (i) the Nepal Health Research Council, Kathmandu, (ii) the Institute of Medi-
cal Sciences, Banaras Hindu University (BHU), Varanasi, India and (iii) the corresponding bodies at
the Institute of Tropical Medicine of Antwerp and the Antwerp University, Belgium, reviewed and
approved the study protocol. Informed written consent was obtained from each patient or his/her
guardian for those <18 years of age. All the patients and caretakers/parents had the study purpose
explained to them in local language.
A total of 204 parasite isolates were obtained from clinically confirmed VL patients in the high
endemic regions of the Indian subcontinent (ISC) by the B.P. Koirala (BPK) Institute of Health Scien-
ces in Dharan (Nepal, Terai, N=98), the Kala-azar Medical Research Center in Muzaffarpur (India,
Bihar, N=98) and the Mymensingh Medical College in Mymensingh (Bangladesh, BD, N=8). The
Indian and Nepalese isolates were collected as part of a multi-center collaborative project to investi-
gate drug resistance in ISC and were all typed as Leishmania (Leishmania) donovani. Complete clini-
cal and epidemiological data were available for the Indian and Nepalese isolates
(Supplementary file 1).
The 204 L. donovani isolates were obtained from confirmed visceral leishmaniasis patients in pre-
vious clinical studies as described elsewhere (Rijal et al., 2013; 2007). PCR-RFLP of the cysteine pro-
teinase gene (Quispe Tintaya et al., 2004) typed all isolates as Leishmania donovani. Strain names
consisted of 2–3 letters that indicated the location of isolation (BD, BHU, BPK), 2–4 digits that indi-
cated the patient number in that location, a forward slash followed by 1–2 digits that indicated when
the sample was isolated (0: before treatment, 1: 1 month after treatment, etc) and optionally the
number of the parasite clone if the strain was cloned (clone one is listed as ’cl1’; clone two is listed
as ’cl2’, etc). Cloning was performed using the micro-drop method (Van Meirvenne et al., 1975).
Patient treatment outcome was monitored at the end of treatment and at 3, 6 and 12 months post-
treatment). Treatment non-response was defined as a case with positive parasitology at the end of
the treatment course. Patients who were successfully cured at the end of treatment but in whom
symptoms re-emerged within the 12 month follow-up period were classified as relapse cases.
Patients who were cured at the end of treatment and remained cured within the 12 month follow-up
period were classified as definite cures. If patients were lost to follow-up, the last known treatment
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outcome was recorded. Seven pre- and post-treatment samples coming from the same patients
were obtained. Patient treatment outcome after treatment with miltefosine (MIL) and pentavalent
antimonials (SSG) was monitored during 12 months (at the end of treatment, month 3, month 6 and
month 12 after treatment).
Sample phenotyping
50 strains were phenotyped for their susceptibility to SSG using a standardized in vitro susceptibility
test as described elsewhere (Downing et al., 2011; Rijal et al., 2007). An SSG-susceptible reference
strain (BPK206/0cl10) was included in each assay. The classification into resistance and susceptible
strains was determined by calculating the activity index (AI): the ratio of the EC50 of the strain in
question versus the EC50 of the susceptible reference strain. AI values clustered strongly, with most
strains showing an AI1 (25; classified as SSG-sensitive) or 6 (18; classified as SSG- resistant). A
few strains (7) showed AI values around 3 and were considered as showing intermediate resistance.
Genome sequencing
DNA isolation, sample preparation, DNA quantification and DNA library preparation were done as
outlined previously (Downing et al., 2011). 100 bp paired-end sequence reads were generated
(median coverage 44 per sample) with the Illumina Hiseq 2000 platform according to standard pro-
tocols. Read data are available under study ERP000140 at the European Nucleotide Archive (http://
www.ebi.ac.uk/ena/data/view/ERP000140).
DNA read mapping
Reads were mapped to the reference L. donovani genome BPK282/0cl4 using Smalt v5.7 (www.
sanger.ac.uk/resources/software/smalt/). Options for exhaustive searching for alignments and ran-
dom assignment of repetitively mapped reads were used to properly estimate read coverage. Non-
mapping read exclusion, read file merging, sorting and elimination of PCR duplicates were imple-
mented with Samtools v0.1.18 and Picard v1.85.
Reference genome masking
The reference genome was masked at regions of the genome that were repetitive, duplicated, close
to contig edges, structurally variable, or potentially mis-assembled. Five criteria masked a total of
6,358,203 bp out of the 32,444,998 bp reference genome sequence for L. donovani BPK282/0cl4,
resulting in SNPs being called at 26,086,795 or 80.4% of the nuclear genome. Criteria were: 1. Man-
ually identified repeats, commonly duplicated or deleted regions, regions with excessive rates of
common SNPs and non-unique regions (Downing et al., 2011) identified with Gnuplot, the Artemis
Comparison Tool, Artemis and Samtools tview (1,740,084 bp). 2. Duplicated regions determined by
DNA similarity as Blast v2.2.25 (Altschul et al., 1990) hits between the two reference genome
sequences for L. donovani BPK282/0cl4 and L. infantum JPCM5, with E-value less than 10e-20
(2,082,546 bp). 3. Low complexity repeat regions determined by Tantan v0.13 (www.cbrc.jp/tantan/
); (2,495,070 bp). 4. 100 bp regions adjacent to each contig edge (1,641,511 bp) – initially 13.8% of
candidate SNPs were in these regions. 5. The first 300 bp and last 5 kb of all chromosomes, which
are more likely to contain mis-assemblies.
SNP detection using COCALL
SNPs were ascertained using a consensus calling approach (COCALL) that is based on the framework
outlined for the 1000 Genomes project (1000 Genomes Project Consortium, 2012). COCALL
applied five different variant detection approaches and combines evidence from them to calculate
the support for each genotype. For complete details on the algorithm testing and development, see
Appendix 1. In short, this approach avoids bias associated with systematic errors unique to each indi-
vidual SNP caller by examining their consistency and identifying discordant mutations symptomatic
of false positives. The five callers used were FreeBayes v0.9.5, GATK 2.0–38, Samtools Pileup
v0.1.16 and Mpileup v0.1.18 based on the DNA read mapping by Smalt, and Cortex v1.0.5.13 based
on its own de novo assembly and mapping. In a large population of genetically homogenous strains,
superior inference power was achieved by examining the population-wide genotype at each candi-
date SNP site (i.e. population-based COCALL; Figure 2—figure supplement 1). Candidate SNPs
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with genotype qualities of 40+ across all five callers were retained. SNPs with population normalized
read depth 0.5 or 1.75 or with multiple derived alleles across the five callers were excluded. Can-
didate SNPs in soft-masked regions were accepted where the number of callers 3.5; those in non-
masked regions were kept where the number of callers 2.5. SNP sites retained in the final set of
retained SNP sites were supported by a mean of 4.5 callers out of 5.
Copy number variant, somy and indel detection
Chromosomal read depths were computed using a trimmed median read depth (calculated as the
median of read depths for sites with depths within one standard deviation of an initial, untrimmed,
median read depth of each chromosome) and normalized as the depth per haploid genome as out-
lined previously (Downing et al., 2011). Somy levels were estimated as the median normalized chro-
mosomal read depths (Downing et al., 2011). Local copy number variants (CNVs) were detected
where the local read depth was significantly different from the median depth of approximately 60
samples from ICS4, ISC6 and ISC8 whose depth profile is similar to that of BPK282/0cl4, and were
measured with respect to the haploid depth to exclude somy variability. Two CNVs in particular, the
MAPK1 and H-locus, were further investigated as they show functions potentially relevant to parasite
adaptation (Downing et al., 2011). A quantitative PCR assay in a subset of 46 samples was per-
formed to confirm the copy number variation of the MAPK1 and H-locus amplicons. The nature of
the amplification (extra- or intra-chromosomal) was determined by pulsed-field gel electrophoresis
(PFGE) and southern blot hybridization comparing two strains that showed differential amplification
of these loci (ISC6 strain BPK282/0cl4: amplification; and ISC1 strain BPK026/0cl5: no amplification).
To exclude the possibility that the amplicons are a culturing artefact, PCRs using primers that
enabled amplification of circular episomes or tandem duplications was also attempted directly on
five bone marrow samples from VL patients. Indels were detected using a consensus calling method
based on the concordance of results across four tools: Cortex, Freebayes, GATK and Samtools Mpi-
leup. For complete details on the Somy, CNV, indel and episome detection, see Appendix 2.
Haplotype inference and linkage disequilibrium
Haplotypes were inferred using PHASE v2.1.1 (Stephens et al., 2001): 0.1% of genotypes in the
Core 191 and 0.9% in ISC1 had confidence scores <0.95. Haplotypes were inferred with a general
recombination rate model (Li and Stephens, 2003) with ten runs, each with a burn-in of 100 steps,
100 iterations and a single MC thinning step and recombination rate estimated for each chromo-
some. Convergence was examined for each chromosome: recombination estimates were consistent,
though there was more variation between phasing runs for chromosome 16 in the core population
and consequently inferred haplotypes are less certain for that chromosome. There was no correlation
between the mean chromosome copy number and mean recombination rate or PHASE probability
values for inferred haplotypes (r2=0.011). While variation in somy is not explicitly accounted for in
the phasing process, the rapid flux in the somy levels of aneuploid chromosomes may mean this vari-
ation has no effect on haplotype inference. Of 3,567 heterozygous sites, 3,076 (86%) had a PHASE
probability of exactly 100% and 437 had PHASE probabilities < 0.95: these lower-confidence haplo-
types were masked. Haplotypes for BHU1087/0 were inferred along with the core population. The
phased core population SNP set had 2,401 SNPs: 17 singletons were masked. The smaller sample
size meant that phasing within ISC1 was less successful: phase was successfully inferred for 2,308
sites using the same (0.95) confidence score threshold: 524 were not phased and were excluded
from further analysis. No correlation between phasing confidence score and trisomy or tetrasomy
was apparent.
Linkage disequilibrium (LD) was inferred as the correlation in genotypes (r2 values) between SNP
pairs using Bcftools v0.1.17 screened with Samtools Mpileup given SNP mapping qualities >30 and
base qualities >25. These pairwise r2 values were used to examine genome-wide LD patterns and LD
decay with distance. Recombination was confirmed using the four-gamete test (Hudson and Kaplan,
1985). Mean chromosomal estimates of LD in the core population did not correlate with somy level
if the tetrasomic chromosome 31 was excluded (r2=0.001) but did if chromosome 31 was included
(r2=0.167). Somy had little impact on the variance of LD per chromosome (r2=0.017 with chr31,
r2=0.000 without chr31). Variance in somy level across chromosomes had no association with either
the mean or variance of LD per chromosome. We calculated zygosity as the probability that a SNP
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exists at a distance d from a SNP at a site x assuming diploidy (Lynch, 2008). No differences
between homozygous and heterozygous SNP clustering measured as a product of chromosomal dis-
tance was observed.
Population genomic identification of groups
L. infantum JPCM5 (MCAN/ES/1998/LLM-877) from Spain and LV9 (MHOM/ET/1967/HU3) from
Sudan were used (Downing et al., 2012) for comparison with the L. donovani genomes generated
in this study. Variants were called for these two samples using the approaches outlined above. For
two additional L. donovani isolates from Sri Lanka (Zhang et al., 2014), we mapped Illumina GAII
reads using Smalt v5.7 as above and called candidate SNPs at non-masked regions using Samtools
Pileup v0.1.16 (Li et al., 2009), followed by screening steps as above. Two genomes were excluded
in the final analyses because sequence reads were of insufficient quality (for MHOM/IN/10/
BHU1087/0) or because of a suspected mixed infection (for MHOM/IN/10/BHU790/0). BHU790/0 is
distantly related to the core population (most likely ISC3) and appears to be a mixed infection rather
than a hybrid because its average read allele frequency of heterozygous SNPs approximates 0.17,
whereas most detected hybrids had mean read allele frequencies of 0.4–0.5. Remaining data were
used to construct phylogenies using the 211,536 sites containing verified SNPs in the entire sample
set (ISC1/2/3/4/5/6/7/8/9/10 and ungrouped, LV9, JPCM5, BPK512/0cl9). JPCM5, LV9, the two Sri
Lankan isolates and one sample from our collection (BPK512/0cl9) represented genetically distinct
lineages, distinct to both the ISC1 (n=12) and core populations (n=191). Seven SNPs in the core pop-
ulation and ten in ISC1 had multiple derived alleles compared to reference genome sample BPK282/
0cl4 (Supplementary file 2, table t). These were included in all diversity analyses, but not those
involving phased haplotypes.
Genome-wide phylogenetic trees were constructed with RAxML v8.1.1 (Stamatakis, 2014) using
the GTR+G substitution model and 1000 bootstrap replicates for 10 runs for the core population
(881 alignment patterns), ISC1 (349 alignment patterns), and all samples including the CL and VL
samples from Sri Lanka (Zhang et al., 2014) (2274 alignment patterns). The best fitting substitution
model determined using MEGA v6 (Tamura et al., 2011) for the core population was GTR+G. The
final phylogenies were visualised using MEGA v6 (Tamura et al., 2011) and Splitstree v4 (Huson and
Bryant, 2006). Unrooted haplotype trees for the phased SNPs for each chromosome were con-
structed from maximum-likelihood distances for the TN93 substitution model using the package Ape
(Paradis et al., 2004) v3.1–4 in R version 3.12.
Samples in the core population of 191 isolates were classified using model-based clustering as
implemented in Structure v2.3.2.1 (Pritchard et al., 2000) and principal component analysis (PCA)
of the allele frequencies. Given a number of genetically distinct clusters (K), samples were probabilis-
tically assigned to a population independent of a mutation model with a prior of 1/K based on the
correlation in genotypes of each sample with estimated population allele frequencies. 1K15 was
examined with admixture and incomplete membership allowed to reduce overfitting. We used 105
burn-in steps before a run of 2x106 steps with three independent runs per K to confirm chain conver-
gence. The most likely number of clusters was based on the second-order rate of change of the like-
lihood function (DK, Evanno et al., 2005). At K=4 the groups were composed of ISC2/3/9/10, ISC4,
ISC5 and ISC6/7/8. Inter-population differentiation was lower for ISC2/3/9/10 (FST=0.36) compared
to the others (0.85<FST<0.98). K=7 was the most probable K value (DK=25.8): the groups were com-
posed of ISC2, ISC3, ISC4, ISC5, ISC6/7/8, and ISC9/10 (all FST>0.79) – the 21 ungrouped samples
collectively had an FST=0. Most population membership assignments were >0.97 with few ambigu-
ous values (range 0.80–0.97). At K=9, ISC6/7/8 split into ISC6 and ISC7/8 (both FST>0.85). At K=10,
ISC7/8 segregated into ISC7 and ISC8.
Inference of historical population sizes, geographic locations and
migration rates
Dated phylogenies, historical population sizes and migration patterns were modelled for the 191
core clinical isolates using BEAST v1.8.1 (Drummond et al., 2012). For molecular clock analyses,
hybrid isolates not assigned to any of the ISC groups were removed from the dataset, as were the
Bangladeshi outgroups for most analyses. Dates for each were fixed to the month of isolation, with
sampling dates for those for which only isolation year data was available estimated during the
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MCMC but given a uniform prior on sampling ages within that year. Broadly consistent date esti-
mates were obtained under three different models: with an uncorrelated lognormal relaxed clock
model and a TVM substitution model and a Bayesian skyride model for population sizes, under the
same model but with a strict clock model and finally under a GTR substitution model, with a simple
constant population size coalescent model for data including the outgroups. Migration rate esti-
mates were obtained by including a simple continuous-time Markov model of a discrete trait repre-
senting the country (Nepal/India) of isolation, so that ancestral states and rates of change in
geographical location were estimated along the phylogeny. All analyses were made with a minimum
of 8 independent MCMC runs, for 200 million update generations per run. Convergence was
assessed by inspection in Tracer v1.6, confirming that at least 5 of the 8 runs had converged to the
same stationary distribution of parameters and that this had the highest likelihood. In most analyses,
seven or eight chains all converged to the same posterior distribution, but the Bayesian skyride anal-
yses converged more slowly. ESS estimates for almost all parameters across runs was over 500,
except for some skyride population size parameters. The first 20 million generations of each MCMC
run were removed before combining all converged runs for inference. Historical population sizes
were estimated both with the Bayesian skyride model and by transforming lineage-through-time
data for all trees in the posterior probability distribution from the strict clock model above using the
package Ape (Paradis et al., 2004) v3.1–4 in R version 3.12. To compare population sizes between
the drug resistant clade and others, we split ISC5 from other data and removed coalescent events
between the ISC groups (the oldest six) to make these comparable with the ISC5 coalescence.
Population genomic identification of admixture using allele frequency
correlations
f-statistics describe the correlation in allele frequencies between populations (Patterson et al.,
2012; Reich et al., 2009). The simplest (f2) is simply the sum-of-squares difference in allele frequency
between two populations averaged across loci, and so captures the amount of divergence, or branch
length between two populations. Two more complex statistics, f3 and f4 are calculated as differences
between f2 statistics between groups of 3 and 4 related populations. f3(C;A,B) has the property that,
for a population C derived from populations A and B, it is expected to be positive if A,B and C are
related by a simple history of divergence and genetic drift, but negative if admixture from A or B
has contributed to the genetic composition of population C, while being robust to the details of the
relationship between the three populations. In contrast, the value of f4(A,B,C,D) does depend on the
evolutionary history of populations A, B, C and D and so can be used to test a proposed relation-
ship: if the four populations are related as ((A,B),(C,D)) the f4 statistic is expected to be zero; for ((A,
C),(B,D)) it is expected to be positive and for ((A,D),(B,C)), negative. Finally, if the evolutionary his-
tory of three ancestral populations is known, the ratio of two f4 ratios is an estimate of the relative
contribution of two potential parental populations to a fourth admixed population, given an
outgroup.
Population genomic identification of admixture using haplotype sharing
Whereas groups ISC2/3/4/5/6/7 seemed clearly defined phylogenetically and by Structure, ISC8/9/
10 were not and no simple relatedness among the 21 ungrouped samples was detected. Conse-
quently, we used inferred haplotypes to test whether these represented genetically discrete popula-
tions, or whether some of those samples were mixtures of ISC3/4/5/6/7 generated by hybridisation
between these groups (Lawson et al., 2012). Chromopainter v0.0.2 and FineStructure v0.0.2
inferred ancestral patterns of haplotype similarity among samples without a prior assumption of a
given number of populations or of independence between mutations.
Co-ancestry matrices for the core population were computed using Chromopainter v0.0.2 as the
number of segments potentially donated to or received from individual samples, using the phased
haplotypes. Recombination rates between pairs of SNPs inferred by PHASE were used for each of
36 unlinked chromosomes. Groups of SNPs on a single chromosome were expected to be
exchanged as blocks of different sizes, so a higher number and longer lengths of shared blocks indi-
cate recent common ancestry. The most likely ancestral sample or population was assigned accord-
ing to its similarity to corresponding segments in a set of donor isolates. Two main datasets were
generated by ChromoPainter: a co-ancestry matrix where all 191 could donate to all 191 as
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recipients (191x191), and another where six representative samples were used as the only donors
(191x6: BD09 for ISC2, BPK067/0cl2 for ISC3, BPK087/0cl11 for ISC4, BPK275/0cl18 for ISC5,
BPK282/0cl4 for ISC6, BHU200/0 for ISC7). The expected number of chunks was minimised for the
six representative samples, with k=80 segments and an effective number of chunks c=0.02. Reducing
the number of representative strains to represent distinct groups identified by Structure with smaller
K parameters resulted in smaller k and larger c values, suggesting that using six representative sam-
ples was the optimal number for discrimination within the core population. Though ISC7 was a sub-
set of ISC6, ISC7 had a large number of fixed SNPs sufficient to differentiate it from ISC6 with
Structure, so it was included. For the 191x191 comparison, k=79 segments was expected and the
effective number of chunks was lower (c=0.00054) because the total diversity of the donor set per
SNP had decreased.
These 191x191 and 191x6 co-ancestry matrices represented the most probable number of seg-
ments copied from each donor to each recipient, and also the relative probability of ancestry across
the set of donors for each SNP for each sample. The number of donors per recipient was set to 100.
20 expectation-maximisation algorithm iterations was sufficient to maximise the recombination-scal-
ing coefficient (Ne) and copying probabilities with 10<k<1000 iterations across different number of
donor samples assuming a minimum recombination rate of 10-15 Morgans/bp. For the 191x191
matrix, the Ne=523.3 and the mutation rate (m) was 0.000181. For the 191x6 matrix, the Ne=1015.1
and m=0.000628: Ne and m were higher because there were more mutations per sample.
The 191x191 matrix was clustered for 106 MCMC (Markov chain Monte Carlo) steps with a burn-
in of 10,000 and a skip of 100 steps using FineStructure v0.02 to obtain aggregated expected seg-
ment sharing between samples and populations with 100 trees examined per merge step. This dis-
tinguished complex ancestral patterns of segment sharing for the strains which Structure could not
fully assign to single populations.
To verify FineStructure and Structure results, the correlation in the SNP allele frequencies across
samples was examined in the core population for six principal components with p<10-7 using PCA
implemented by smartPCA in Eigensoft v4.2 (Price et al., 2006). The first PC separated ISC2 (10.1%
of all variation), the second ISC4 (6.4%), the third ISC5 (5.8%), the fourth ISC3 (4.9%), the fifth
BPK035/0cl1 and BPK043/0cl2 (4.2%) and the sixth a subset from ISC9/10 (3.9%). This was repeated
for the 2353 variable sites in the core population (ISC3/4/5/6/7/8/9/10 and ungrouped samples,
n=183) excluding the 8 samples from Bangladesh (ISC2). This partitioned ISC5 (PC1, 7.4%), then
ISC4 (6.8%), third ISC3 (5.6%), and fourth BPK035/0cl1-BPK043/0cl2 (4.8%). Eigenstrat and FineS-
tructure PCA results were effectively the same but with some different axis labels – PC1 in the for-
mer was PC3 in the latter. FineStructure 191x191 ancestry patterns partitioned ISC4 vs ISC6 over
PC1 (16.8% of variation), and ISC5 vs ISC6 over PC2 (15.5%). The next (12.3%) differentiated ISC2,
and PCs 4 (6.4%) and 5 (5.7%) separated ISC3. PC6 in FineStructure differentiated the BPK035/0cl1-
BPK043/0cl2 pair.
Population genomic identification of drug-resistance elements
Information on in vitro SbV-resistance was available for 50/191 Core 191 isolates, from which 25
were sensitive and 25 resistant (Supplementary file 1). Links between genetic diversity (SNP, indel,
CNV and somy) and in vitro SbV-resistance were assessed using the Fisher Exact test (FET), Mann
Whitney U-tests (MWU) and odds ratios (ORs), implemented on 103 CNVs and 17 indels (in 14
genes) as well as 2,392 phased SNPs genotypes. SNPs were assigned to the 5’ and 3’ UTR if they
were within 1 kb of the start or end of the gene (respectively). To counter bias associated with the
small sample size, FET and MWU were used initially. For the FET, variants were defined as discrete
variables: SNPs as 0, 1 or 2 non-reference alleles, and small indels as the diploid number of inserted
or deleted basepairs. For the MWU, mutations were considered as a continuous variable such that
the somy state was the haploid chromosome state, and CNVs were the haploid copy number times
the somy state. The null hypothesis was that there were no significant genetic differences between
SbV-R and SbV-S strains (subject to p<0.01). The FETs and MWU were limited by the partial associa-
tion of different mutations with the phenotypes, so we examined ORs of the derived alleles segre-
gating in multiple ISC populations with 6+ non-reference alleles for which the absolute difference in
SbV-R and SbV-S allele frequencies >0.1 using the log-scaled EC50 values. We compared the log-
scaled EC50 values of each allele pair using t-tests.
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We also examined samples for which the patient was treated with SbV and was either cured or
not, samples for which the patient was treated with miltefosine (MIL) and was either cured or not,
and also in vitro MIL resistance levels as implemented above for SbV.
Testing for selective processes among ISC populations
Evidence of historical differences in selective processes on the ancestors of the major ISC popula-
tions was assessed as the rate of accumulation of derived alleles. Stronger purifying selection should
purge deleterious derived alleles more quickly, detected as an excess of nonsynonymous changes
relative to synonymous ones, as previously observed for ISC isolates (Downing et al., 2011). This
signature should be most apparent for derived alleles, which should accumulate at a net rate depen-
dent on the historical effective population sizes and selective coefficients. Using L. infantum JPCM5
as the outgroup, the relative abundance of derived alleles in one population that were absent in the
other for each ISC population pair (ISC2-7) were determined as the statistic R (Do et al., 2015). The
associated ratio R2 denoted the relative rate of homozygous derived allele accumulation between
populations. R and R2 should approximate 1 assuming no difference in the strength of selection,
and primarily depend on the derived allele frequency per population, so the main confounder was
variance in historical effective population sizes among ISC populations. To calculate confidence inter-
vals for these R values that take into account correlation between neighbouring sites, we used a
Weighted Block Jackknife by splitting the SNPs according to chromosome (Busing et al., 1999) to
counter the extensive linkage disequilibrium between SNPs (Moorjani et al., 2011): discrete chro-
mosomal blocks may still be linked. This was adjusted for the number of SNPs per block to reflect
the variability in the relative selective pressure (Kunsch, 1989). A threshold of four times the stan-
dard error of these jackknife estimates was used as a criteria for identifying comparisons deviating
significantly from expected values (Do et al., 2015).
AQP1 modelling
A protein model of the intact Leishmania donovani AQP1 from BPK282/0cl4 was created using
MODELLER 9.14 (Sali and Blundell, 1993). The template for homology modelling was the crystal
structure of the aquaglyceroporin from Plasmodium falciparum in complex with glycerol (PDB code:
3c02) published by Newby and co-workers (Newby et al., 2008). The sequence identity between
the target and the template was approximately 33%. PyMOL version 1.50.04 (Schro¨dinger) was used
to generate the biological units for the aquaglyceroporin from Plasmodium falciparum (generation
of symmetry mates function in pymol). The C-alpha atoms of chain A, B, C and D of the tetramer
template were restrained during homology modeling using MODELLER in order to reduce the num-
ber of interatomic distances that needed to be calculated.
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. Supplementary file 2. (a) Numbers and types of mutations in the core population compared to
genetically distinct strains LV9 (MHOM/ET/1967/HU3) and JPCM5 (MCAN/ES/1998/LLM-877), as
well as the ISC1/2. N/S ratio denotes the number of nonsynonymous SNPs divided by the
synonymous ones. The ’LV9+JPCM5-191 lineage’ refers to homozygous SNPs occurring in the core
population ancestral branch only since its divergence with LV9 and JPCM5. The ’ISC1-191 lineage’
refers to fixed homozygous SNPs between all of the core population and all of ISC1. The ’ISC2-183
lineage’ refers to fixed homozygous SNPs between ISC2 (Bangladesh) and ISC3/4/5/6/7/8/9/10 and
ungrouped isolates (India or Nepal). (b) Number of SNPs unique to each population or lineage.
SNPs were determined as unique where their intraspecific frequency was >0.95 and <0.05 in all
other samples (excluding ungrouped samples). The number of samples did not reflect the number of
SNPs or haplotypes: haplotype diversity was >0.99 for all groups except ISC7 (0.34). (c) Genes
ordered by ID with two or more SNPs and p/kb>1. The non-synonymous variant V185M in a NADH-
flavin oxidoreductase/NADH oxidase gene (LdBPK_120730) was present here in the ISC1/2/3 as well
as previously being observed in Kenyan L. donovani (Downing et al., 2012). 956 genes had at least
one SNP, of which 566 had SNPs that were not singletons. Only 63 genes contain 2 SNPs and 12
genes contain 3 SNPs. (d) Mean numbers of SNP differences within and between groups. Rows
and columns denote comparisons: within populations, the mean number of SNPs between strain
pairs (p) is shown; and between populations, the mean number of SNPs between samples from each
population is given. Within the core population, there was an excess of singletons (Tajima’s D=-2.2,
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p<0.01, Fu and Li’s D=-0.78, Fu and Li’s F=-1.87: the values were the same with either JPCM5 or
LV9 as the outgroup). 62.6% of SNPs occurred in one sample only and the correlation of the number
of homozygous and heterozygous SNPs per sample was small (r2=0.005). 291 distinct haplotypes
out of a maximum possible of 382 were resolved in the phased SNPs, with a resulting haplotype
diversity (Hd) of 0.994. Nepalese samples were on average more diverse compared to the
Indian ones (p=84.3 per Mb vs 66.5, Hd=0.996 vs 0.982). ISC6 was restricted to Nepal (p=12.2 per
Mb). (e) Branch distances between groups using the 2 population (f2) statistic. The scaled correlation
in allele frequencies were computed for each reference group (top row) and groups (first column).
ISC9 and ISC10 were examined together as one group. The distribution of allele sharing across
ISC3/4/5/6 in subsets of trios was compared to that for ISC2 using F-statistics. The relative pairwise
correlation in allele frequencies between populations using the f2 test indicated ISC2 as the most
consistently divergent population and also highlighted distinctive allele frequencies in the recently
emerged Indian ISC7 group. In contrast, groups with possible admixture (ISC9 and ISC10) had much
shorter branch lengths. (f) f4 ratios for candidate admixed populations for mixture from ISC5, ISC6
and ISC7.Each ratio was computed as f4ðA;outgroup;B;XÞ
f4ðA;outgroup;B;ISC5Þ
with A and B as either ISC6 or ISC7. Popula-
tions X were the 6 samples identified as possible mixtures of the ancestors of ISC5 and ISC6/7:
BHU815/0, BHU764A1, BHU274/0, BHU574cl4, BHU581cl2, and BHU572cl3. The gene flow from
ISC5 was the f4 ratio and that from B (ISC6 or ISC7) was 1-f4. As expected, if ISC6 and 7 grouped
together relative to other groups (f4>0). f4 statistics were considered to support a particular rela-
tionship between four individual isolates if 0.05<f4<0.05. ISC2 clustered with ISC3 much more fre-
quently (66.7%) than any other (ISC4, ISC5, ISC6 all 22.2% each). ISC3 had drift patterns more
similar to ISC4 (44.4%) than ISC6 (22.2%) or ISC5 (0%). ISC4 had greater correlation with ISC5
(44.4%) than ISC6 (22.2%). ISC5 and ISC6 had more similar drift in 66.7% of tests. These values are
consistent with the relationship (ISC2,(ISC3,(ISC4,(ISC5,ISC6))))) shown by the phylogenetic analysis.
Admixture levels were measured for the six ISC5-ISC6/7 hybrids as a single population using f4 ratios
with ISC2, ISC3 and ISC4 as outgroups. The six hybrids were BHU815/0, BHU764A1, BHU274/0,
BHU574cl4, BHU581cl2 and BHU572cl3. The fraction of ancestry attributed to ISC5 was 54–56% and
to ISC6 was 44–46% for ISC5-ISC6 mixing, and the alternative ISC5-ISC7 mixture had ISC5 at 59–
61% and ISC7 at 39–41%. (g) Diagnostic SNPs for ISC7. 20 mutations were unique to ISC7 compared
to the other genetically homogeneous populations (ISC2/3/4/6/7/8/9/10) with a ISC7 frequency
>0.98 and a non-ISC7 frequency <0.02. Six were nonsynonymous. These SNPs coincided with a dis-
tinct chromosome copy number pattern in ISC7. SNPs were assigned to the 5’ and 3’ UTR if they are
within 1 Kb of the start or end of the gene (respectively). ISC7 was a recent radiation restricted to
India (p=1.8 per Mb). (h) Diagnostic SNPs for ISC5. 32 mutations were unique to ISC5 compared to
the other genetically homogeneous populations (ISC2/3/4/6/7/8/9/10), with ISC5 frequency >0.95
and a non-ISC5 frequency <0.05. Eight changes were nonsynonymous. *Nine were previously associ-
ated with antimonial resistance, including four samples from this ISC5 dataset (Downing et al.,
2011): six of these would change the amino acid sequence. SNPs were assigned to the 5’ and 3’
UTR if they are within 1 Kb of the start or end of the gene (respectively). (i) Diagnostic SNPs for
disomic clade within ISC5. 16 diagnostic SNPs unique to a subset of the ISC5 associated with an
expansion of disomic strains from polysomic ancestors (BHU1216/0, BHU239/0, BHU271/0, BHU267/
0, BHU800/1, BBU269/0, and BHU273/0). Each SNP had a read-depth allele frequency >0.978 within
this group and a frequency <0.04 in the other strains not in this group. These SNPs coincided with a
distinct chromosome copy number pattern in this group. Ref is the reference genome BPK282/0cl4
allele and Var is the observed derived one. (j) Linkage disequilibrium (LD) and SNP density across
chromosomes in the core population. LD was computed as the r2 values between SNP pairs. SD is
the standard deviation. The number of homozygous (hom) and heterozygous (het) mutations per
chromosome across all 191 samples is shown. LD was markedly higher for chromosome 31, and
lower for 1, 6, 7, 8 and 10. The number of recombinant pairs was largest on chr31 (469), which had
the highest somy level and was the most SNP-dense chromosome. (k) A genomic map of SNPs in
the core population whose ancestry could be assigned to a population. Using the 191x6 Chromo-
Painter model, the 610 ancestry-informative SNPs were examined to highlight those with probabili-
ties of being donated given ISC group was >0.4: ISC2 (gold), ISC3 (grey), ISC4 (red), ISC5 (green),
ISC6 (blue) and ISC7 (light blue). The representative samples used for the 191x6 ChromoPainter
model were BD09 (ISC2), NEP123/6 (ISC3), BPK087/0cl1 (ISC4), BPK275/0cl18 (ISC5), BPK282/0cl4
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(ISC6) and BHU200/0 (ISC7). SNPs with probabilities <0.4 are uncoloured. For chr32 and chr35, most
recombinant pairs could be attributed to the eight ungrouped hybrid isolates. (l) Number and
heterozygosity of ancestry-informative SNPs per isolate. The number of homozygous (hom) and
heterozygous (het) SNPs distinguishing each core sample (191 total) from six representative samples
from each genetically distinct ISC population: ISC2 (BD09), ISC3 (NEP123/6), ISC4 (BPK087/0cl1),
ISC5 (BPK275/0cl18), ISC6 (BPK282/0cl4) and ISC7 (BHU200/0). There were 610 informative SNPs
with an ancestry probability threshold >0.4. The relative ratio of homozygous and heterozygous
SNPs denoted the genetic relatedness of the strains. Samples possessing recent common ancestry
with the representative strains had few homozygous SNPs but the same rate of heterozygous SNPs
compared to other representative samples. Similarly, samples possessing recent common ancestry
with multiple representative samples had fewer homozygous SNPs and no change in the heterozy-
gous SNPs. This was apparent for highlighted ungrouped samples BHU815/0, BHU764A1, BHU274/
0, BHU574cl4, BHU581cl2, BHU572cl3 (all ISC5/6/7: green and blue); and BHU744/0, BHU774/0
(ISC6/7: blue). In many groups haplotype segments were shared across isolates widely separated in
sampling date. For example, in ISC3, 35 haplotype segments were shared between NEP123/6
(2004), BPK507/0 (December 2009), BPK515/0, BPK518/0 and BPK519/0 (all February 2010); 53 hap-
lotype segments were shared between BPK157/0cl5 (October 2002) and BPK602/0 (February 2011)
(both ISC9); 44 between BPK280/0 (August 2003) and BPK615/0 (March 2011; both ungrouped); 31
between BHU274/0 (ungrouped, August 2007) with BHU1199/0 (ISC9, November 2010). (m) Distri-
bution of copying probabilities of SNPs in two representative isolates. Expected copying probabili-
ties from Chromopainter assigning ancestry to SNPs from BHU581/0 (Ungrouped, left) and BPK275/
0cl18 (ISC5, right) using probabilities derived from a model assigning SNP ancestry to representative
samples from ISC2/3/4/5/6/7. Each column shows the percentage of SNPs assigned to each percent-
age probability of being donated from each population (eg ISC2) for a particular sample (eg
BHU581/0). If many SNPs had high probabilities of being donated from a particular population, this
implied that sample shared a recent ancestor with that population. BHU581/0 was a putative ISC5/6/
7 hybrid, and had 9.4% of its SNPs with ancestry from ISC6 or ISC7, 7.2% from ISC7, and 10.9%
from ISC5. In contrast, BPK275/0cl18 was the representative sample for ISC5, and 44.3% of its SNPs
had confident ancestry from ISC5. No SNPs from any comparison were assigned probabilities
between 50–95%, hence these rows are omitted from the table. These ancestry patterns indicated
that BPK035/0cl1-BPK043/0cl2, BHU1011/0-BHU770/0cl1, BPK280/0-BPK615/0 and BPK158/0cl9
represented ISC4-related isolates but not mixtures. BHU774/0 and BHU744/0, showed evidence of
both ISC6- and ISC7-derived segments. The six ungrouped samples (BHU274/0, BHU815/0,
BHU764/0cl1, BHU574cl4, BHU572cl3 and BHU581cl2) were sampled between February 2007 and
February 2010 and had high numbers of heterozygous SNPs. High heterozygosity could be symp-
tomatic of genetically distinct parents in a hybrid. For example, if BHU572cl3 and BHU581cl2 (both
May 2009) were mixes of ISC5 (BHU573/0, May 2009) and ISC7 (BHU200/0, July 2006) then only 16
out of 280 genotypes (BHU572cl3) and 15 out of 278 genotypes (BHU581cl2) would be unexplained.
This was evaluated for different haplotype sharing options and matched the timing of samples
(BHU572cl3, BHU574cl4 and BHU581cl2 in relation to BHU573/0; BHU815/0 in relation to BHU816/
0). SNPs assigned to populations with a high probability in the 191x6 model provided a framework
for predicting strain membership as well as admixture. Comparing the relative difference in distribu-
tions of homozygous and heterozygous SNPs between candidate parents within the sample set was
sufficient to identify shared ancestry where related lineages were sampled, and visible in the aligned
genotypes of the six strains with segments of both ISC5 and ISC6 ancestry. (n) Percentage of haplo-
type segment copies shared within and between groups. Recipients are shown as columns and
donors as rows. Groups with complex ancestries received more segments than they donated: ISC8
from ISC5, ISC6 and ISC7; ISC3, ISC9 and ISC10 from ISC5. These ’recipient’ groups were also asso-
ciated with long external branch lengths in phylogenies. The expected probability per SNP in each
population for the 191x191 co-ancestry analysis indicated that strains assigned to populations by
Structure were assigned the same one with FineStructure (ISC2/3/4/5/6/7): ISC2 (copying probability
>99%), ISC3 (>97%), ISC4 (>98%), ISC5 (>99%), ISC6 (>90%) and ISC7 (>97%). Genetically heteroge-
neous groups showed a higher rate of segments were received than donated from specific popula-
tions: ISC8 from ISC5 (11.3% vs 1.7%), ISC6 (16.6% vs 4.7%) and ISC7 (16.5% vs 6.2%). ISC9 (10.0%
vs 0.8%) and ISC10 also received more from ISC5 (11.1% vs 2.5%). ISC5 also donated more to ISC3
(11.0% v 1.9%) suggesting possible ancestral genetic exchange, which may be associated with the
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long branch lengths leading to ISC3. (o) Four-gamete test for recombination. Four gamete tests
showed evidence of recombination in the core population and ISC1. 2043 from 117,055 (1.75%) SNP
pairs had a recombination signature in the core population. For the subset of 2,015 SNPs with no
missing data R=0.7/Mb. The 8 hybrids were BHU815/0, BHU764A1, BHU274/0, BHU574cl4,
BHU581cl2, BHU572cl3 (all ISC5+ISC6/7), BHU744/0 and BHU774/0 (both ISC6/7 only).
Recombination was evident at 25% of SNPs in ISC1 (184,827 out of 739,581 SNP pairs) based on the
four gamete test. This signature varied over 13-fold from chr31 (54.2% of pairs) to chr23 (4%).
(p) SNP and indel association with SbV resistance. Fisher exact tests evaluated the association of
SbV-resistance with SNPs (coded as the number of derived mutations: 0, 1 or 2) and indels (coded as
the diploid number of inserted or deleted (-) basepairs). (q) SNP association with in-vitro SSG
phenotype. SNPs with derived alleles in multiple ISC groups with 6+ non-reference genotypes for
which the absolute difference in SSG-R and SSG-S allele frequency was >0.1 with the OR (odds ratio)
>4 and Benjamini-Hochberg-Yekutieli corrected t-test p value <0.005. SNPs are ordered by
chromosome and position. The SSG phenotypes were assessed as ln(EC50) values for the derived
(D) and reference (R) alleles. To avoid arbitrarily categorising the sample in vitro SbV phenotypes as
R and S using a given threshold EC50 value, we compared the log-scaled EC50 values of each allele
pair at the 57 SNPs identified using t-tests (p<0.005): the SbV-R alleles had log-scaled EC50 values
of 1.13–1.84 compared to S ones of 0.01–0.50 (Supplementary file 1). Consequently, the 57 SNPs
together have power to differentiate SbV-R and SbV-S phenotypes. (r) SNP association with clinical
outcome from SSG treatment. SNPs with derived alleles in multiple ISC groups with 6+ non-refer-
ence genotypes for which the absolute difference in SSG-cure and SSG-failure allele frequency
was >0.1 with the OR (odds ratio) >4. The SNPs are ordered by chromosome and position. The SSG
phenotypes were assessed for the derived (D) and reference (R) alleles. We examined lines for which
the patient was treated with SSG and was either cured (n=21) or treatment failed (n=14: death,
relapse, no response to treatment) to test a null hypothesis that SSG outcome and SNPs were
unlinked. An alternative hypothesis was that SSG-cure patients could be infected with SbV-S para-
sites, and SSG-fail with SbV-R (Supplementary file 2). 32 SNPs were associated with SSG cure
(OR>4), including 11 nonsynonymous SNPs, but none at a significant level due to the small sample
size. (s) Relative strength of purifying selection between ISC populations. Relative strength of purify-
ing selection between ISC populations (columns 1 and 2) as ascertained as the relative rate of accu-
mulation of derived alleles computed as R for all (top), nonsynonymous (middle) and synonymous
(bottom) sites. We tested for differential selective pressures among the ISC groups where observed
values of R statistics deviated by at least four standard errors (SE) from the expected value of 1 (Do
et al 2015). The genome-wide values are shown along with the weighted block jackknife
confidence intervals (lower, median, upper). Derived alleles were more frequent in ISC4 than ISC5,
suggesting stronger purifying selection in ISC5. Comparing ISC2 (Bangladesh) to ISC3-7 (Nepal/
India), we found a genome-wide (RG) excess of derived alleles had accumulated in the latter
(RG=0.74, 6.15*SE). This was not directly attributable to selection because the difference was pres-
ent in both nonsynonymous (RN=0.59, 4.42*SE) or synonymous sites (RS=0.66, 10.82*SE). ISC3/4/5/
6 shared genetic ancestors dating to approximately the same origin, so a comparison of their rates
should indicate variation in the relative accrual of derived alleles. Despite possessing the largest
sample size (n=52) of all ISC populations, ISC5 gained significantly fewer derived alleles genome-
wide compared to ISC3 (RG=0.75, 11.39*SE), ISC4 (RG=0.65, 7.37*SE) and to a lesser extent, ISC6
(RG=0.82, 3.38*SE). This trend was present in both nonsynonymous and synonymous SNPs but not
significant for most comparisons (an exception was comparing synonymous changes in ISC5 vs ISC4
(RS=0.37, 7.80*SE). Similarly, the rate of accumulation of homozygous derived SNPs (R2 values) was
higher in ISC4 relative to ISC5 (R2G=0.90, 3.87*SE). Antimonial in vitro resistance was highest in
ISC5 (ln[EC50]=1.38 ± 1.45) and lowest in ISC4 (0.13 ± 1.12). Consequently, the relative difference in
the rate of accumulation of derived alleles in ISC5 that was predominantly isolated in India may
reflect different exposure to drug selection compared to ISC4 (mainly from Nepal). Further work is
required to quantify this in relation to variable antimonial resistance levels among samples in
each population. ISC7 was a genetic subgroup of ISC6 that may be a recent radiation or have
undergone a substantial population bottleneck. No genome-wide difference was evident in terms of
selction, but fewer derived synonymous SNPs were found in ISC6 (RS=2.18, 4.44*SE), suggestive
stronger hitchhiking of alleles in ISC7. (t) Multi-allelic sites. Sites with multiple derived alleles
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compared to reference genome sample BPK282/0cl4 in the core population (7, top) and ISC1 (10,
bottom).
DOI: 10.7554/eLife.12613.018
Major datasets
The following dataset was generated:
Author(s) Year Dataset title Dataset URL
Database, license,
and accessibility
information
The Wellcome Trust
Sanger Institute
2015 Genomic diversity in Leishmania
donovani in Indian subcontinent
http://www.ebi.ac.uk/
ena/data/view/
ERP000140
Publicly available at
European Nucleotide
Archive (accession no.
ERP000140)
References
1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker
RE, Kang HM, Marth GT, McVean GA. 2012. An integrated map of genetic variation from 1,092 human
genomes. Nature 491:56–65. doi: 10.1038/nature11632
Alam MZ, Kuhls K, Schweynoch C, Sundar S, Rijal S, Shamsuzzaman AK, Raju BV, Raju BV, Salotra P, Dujardin JC,
Scho¨nian G. 2009. Multilocus microsatellite typing (mLMT) reveals genetic homogeneity of leishmania donovani
strains in the indian subcontinent. Infection, Genetics and Evolution 9:24–31. doi: 10.1016/j.meegid.2008.09.
005
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. Journal of
Molecular Biology 215:403–410. doi: 10.1016/S0022-2836(05)80360-2
Alvar J, Ve´lez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, WHO Leishmaniasis Control
Team. 2012. Leishmaniasis worldwide and global estimates of its incidence. PloS One 7:e35671. doi: 10.1371/
journal.pone.0035671
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Menard D. 2014. A molecular marker of
artemisinin-resistant plasmodium falciparum malaria. Nature 505:50–55. doi: 10.1038/nature12876
Baker N, Glover L, Munday JC, Aguinaga Andres D, Barrett MP, de Koning HP, Horn D. 2012. Aquaglyceroporin
2 controls susceptibility to melarsoprol and pentamidine in african trypanosomes. Proceedings of the National
Academy of Sciences of the United States of America 109:10996–11001. doi: 10.1073/pnas.1202885109
Boelaert M, Meheus F, Sanchez A, Singh SP, Vanlerberghe V, Picado A, Meessen B, Sundar S. 2009. The poorest
of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Tropical
Medicine & International Health 14:639–644. doi: 10.1111/j.1365-3156.2009.02279.x
Brotherton MC, Bourassa S, Leprohon P, Le´gare´ D, Poirier GG, Droit A, Ouellette M. 2013. Proteomic and
genomic analyses of antimony resistant Leishmania infantum mutant. PLoS One 8:e81899. doi: 10.1371/journal.
pone.0081899
Busing FMTA, Meijer E, Van Der Leiden R. 1999. Delete-M Jackknife for Unequal M . Statistics and Computing 9:
3–8.
Carver T, Berriman M, Tivey A, Patel C, Bo¨hme U, Barrell BG, Parkhill J, Rajandream MA. 2008. Artemis and
ACT: viewing, annotating and comparing sequences stored in a relational database. Bioinformatics 24:2672–
2676. doi: 10.1093/bioinformatics/btn529
Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, Al Saai S, Phyo AP, Moo CL, Lwin KM, McGready R,
Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp AM, Mayxay M, Newton PN, White NJ, Nosten F, Ferdig
MT, Anderson TJ. 2012. A major genome region underlying artemisinin resistance in malaria. Science 336:79–
82. doi: 10.1126/science.1215966
Chowdhury R, Mondal D, Chowdhury V, Faria S, Alvar J, Nabi SG, Boelaert M, Dash AP. 2014. How far are we
from visceral leishmaniasis elimination in Bangladesh? an assessment of epidemiological surveillance data. PLoS
Neglected Tropical Diseases 8:e3020. doi: 10.1371/journal.pntd.0003020
Decuypere S, Rijal S, Yardley V, De Doncker S, Laurent T, Khanal B, Chappuis F, Dujardin JC. 2005. Gene
expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal.
Antimicrobial Agents and Chemotherapy 49:4616–4621. doi: 10.1128/AAC.49.11.4616-4621.2005
Decuypere S, Vanaerschot M, Brunker K, Imamura H, Mu¨ller S, Khanal B, Rijal S, Dujardin JC, Coombs GH. 2012.
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.
PLoS Neglected Tropical Diseases 6:e1514. doi: 10.1371/journal.pntd.0001514
den Boer M, Argaw D, Jannin J, Alvar J. 2011. Leishmaniasis impact and treatment access. Clinical Microbiology
and Infection 17:1471–1477. doi: 10.1111/j.1469-0691.2011.03635.x
Denton H, McGregor JC, Coombs GH. 2004. Reduction of anti-leishmanial pentavalent antimonial drugs by a
parasite-specific thiol-dependent reductase, TDR1. The Biochemical Journal 381:405–412. doi: 10.1042/
BJ20040283
DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA,
McKennaHanna AM, McKennaRivas AMA, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB,
Imamura et al. eLife 2016;5:e12613. DOI: 10.7554/eLife.12613 22 of 39
Research article Epidemiology and global health Microbiology and infectious disease
Altshuler D, Daly MJ. 2011. A framework for variation discovery and genotyping using next-generation DNA
sequencing data. Nature Genetics 43:491–498. doi: 10.1038/ng.806
Do R, Balick D, Li H, Adzhubei I, Sunyaev S, Reich D. 2015. No evidence that selection has been less effective at
removing deleterious mutations in Europeans than in Africans. Nature Genetics 47:126–131. doi: 10.1038/ng.
3186
Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH, Cotton JA, Hilley JD, de Doncker S, Maes I,
Mottram JC, Quail MA, Rijal S, Sanders M, Scho¨nian G, Stark O, Sundar S, Vanaerschot M, Hertz-Fowler C,
Dujardin JC, Berriman M. 2011. Whole genome sequencing of multiple Leishmania donovani clinical isolates
provides insights into population structure and mechanisms of drug resistance. Genome Research 21:2143–
2156. doi: 10.1101/gr.123430.111
Downing T, Stark O, Vanaerschot M, Imamura H, Sanders M, Decuypere S, de Doncker S, Maes I, Rijal S, Sundar
S, Dujardin J-C, Berriman M, Scho¨nian G. 2012. Genome-wide SNP and microsatellite variation illuminate
population-level epidemiology in the Leishmania donovani species complex. Infection, Genetics and Evolution
12:149–159. doi: 10.1016/j.meegid.2011.11.005
Drummond AJ, Suchard MA, Xie D, Rambaut A. 2012. Bayesian phylogenetics with BEAUti and the BEAST 1.7.
Molecular Biology and Evolution 29:1969–1973. doi: 10.1093/molbev/mss075
Dye C, Wolpert DM. 1988. Earthquakes, influenza and cycles of Indian kala-azar. Transactions of the Royal
Society of Tropical Medicine and Hygiene 82:843–850.
Ebersberger I, Metzler D, Schwarz C, Pa¨a¨bo S. 2002. Genomewide comparison of DNA sequences between
humans and chimpanzees. American Journal of Human Genetics 70:1490–1497. doi: 10.1086/340787
Evanno G, Regnaut S, Goudet J. 2005. Detecting the number of clusters of individuals using the software
structure: a simulation study. Molecular Ecology 14:2611–2620. doi: 10.1111/j.1365-294X.2005.02553.x
Fernandes AC, Soares DC, Saraiva EM, Meyer-Fernandes JR, Souto-Padro´n T. 2013. Different secreted
phosphatase activities in Leishmania amazonensis. FEMS Microbiology Letters 340:117–128. doi: 10.1111/
1574-6968.12080
Freudenberg-Hua Y, Freudenberg J, Kluck N, Cichon S, Propping P, No¨then MM. 2003. Single nucleotide
variation analysis in 65 candidate genes for CNS disorders in a representative sample of the European
population. Genome Research 13:2271–2276. doi: 10.1101/gr.1299703
Fre´zard F, Demicheli C, Ferreira CS, Costa MA. 2001. Glutathione-induced conversion of pentavalent antimony
to trivalent antimony in meglumine antimoniate. Antimicrobial Agents and Chemotherapy 45:913–916. doi: 10.
1128/AAC.45.3.913-916.2001
Garrison E, Marth G. 2012. Haplotype-based variant detection from short-read sequencing. arXiv:1207.3907.
Gibson ME. 1983. The identification of kala-azar and the discovery of Leishmania donovani. Medical History 27:
203–213.
Gourbal B, Sonuc N, Bhattacharjee H, Legare D, Sundar S, Ouellette M, Rosen BP, Mukhopadhyay R. 2004. Drug
uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. The Journal of Biological
Chemistry 279:31010–31017. doi: 10.1074/jbc.M403959200
Gutenkunst RN, Hernandez RD, Williamson SH, Bustamante CD. 2009. Inferring the joint demographic history of
multiple populations from multidimensional SNP frequency data. PLoS Genetics 5:e1000695. doi: 10.1371/
journal.pgen.1000695
Han E, Sinsheimer JS, Novembre J. 2014. Characterizing bias in population genetic inferences from low-coverage
sequencing data. Molecular Biology and Evolution 31:723–735. doi: 10.1093/molbev/mst229
Hudson RR, Kaplan NL. 1985. Statistical properties of the number of recombination events in the history of a
sample of DNA sequences. Genetics 111:147–164.
Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies. Molecular Biology and
Evolution 23:254–267. doi: 10.1093/molbev/msj030
Iqbal Z, Caccamo M, Turner I, Flicek P, McVean G. 2012. De novo assembly and genotyping of variants using
colored de Bruijn graphs. Nature Genetics 44:226–232. doi: 10.1038/ng.1028
Kunsch HR. 1989. The Jackknife and the Bootstrap for General Stationary Observations. The Annals of Statistics
17:1217–1241. doi: 10.1214/aos/1176347265
Lakhal-Naouar I, Jardim A, Strasser R, Luo S, Kozakai Y, Nakhasi HL, Duncan RC. 2012. Leishmania donovani
argininosuccinate synthase is an active enzyme associated with parasite pathogenesis. PLoS Neglected Tropical
Diseases 6:e1849. doi: 10.1371/journal.pntd.0001849
Lawson DJ, Hellenthal G, Myers S, Falush D. 2012. Inference of population structure using dense haplotype data.
PLoS Genetics 8:e1002453. doi: 10.1371/journal.pgen.1002453
Leprohon P, Le´gare´ D, Raymond F, Madore E, Hardiman G, Corbeil J, Ouellette M. 2009. Gene expression
modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in
antimony-resistant Leishmania infantum. Nucleic Acids Research 37:1387–1399. doi: 10.1093/nar/gkn1069
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R.1000 Genome Project
Data Processing Subgroup. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:
2078–2079. doi: 10.1093/bioinformatics/btp352
Li N, Stephens M. 2003. Modeling linkage disequilibrium and identifying recombination hotspots using single-
nucleotide polymorphism data. Genetics 165:2213–2233.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Lim S,
AlMazroa MA, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo
S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Abdulhak AB, Birbeck G, Blyth F, Bolliger I,
Lim S, Bucello C, Lim S, Burney P, Carapetis J, Chen H, Chou D, Lim S, Coffeng LE, Lim S, Colquhoun S, Colson
Imamura et al. eLife 2016;5:e12613. DOI: 10.7554/eLife.12613 23 of 39
Research article Epidemiology and global health Microbiology and infectious disease
KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui
MH, Lim S, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais
DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V,
Foreman K, Forouzanfar MH, Fowkes FGR, Franklin R, Fransen M, Foreman K, Gabriel SE, Gakidou E, Gaspari
F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ,
Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Foreman K,
Khoo J-P, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL,
Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi
BM, McAnulty JH, McDermott MM, McGrath J, Memish ZA, Memish ZA, Merriman TR, Michaud C, Miller M,
Miller TR, Mock C, Mocumbi AO, Mokdad AA, Foreman K, Mulholland K, Nair MN, Naldi L, Narayan KMV,
Foreman K, Foreman K, O’Donnell M, Omer SB, Foreman K, Osborne R, Ozgediz D, Pahari B, Pandian JD,
Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA, Porrini E, Pourmalek F, Raju M,
Ranganathan D, Lim S, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leo´n FR, Rosenfeld LC, Rushton L, Sacco
RL, Salomon JA, Sampson U, Foreman K, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J,
Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA,
Venketasubramanian N, Vijayakumar L, Lim S, Wagner GR, Naghavi M, Wang W, Watt K, Weinstock MA,
Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh P-H, Yip P, Zabetian A, Zheng Z-J, Lopez AD, Murray CJL,
Shibuya K, Aboyans V, Memish ZA. 2012. Global and regional mortality from 235 causes of death for 20 age
groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380:
2095–2128. doi: 10.1016/S0140-6736(12)61728-0
Lukes J, Mauricio IL, Scho¨nian G, Dujardin JC, Soteriadou K, Dedet JP, Kuhls K, Tintaya KW, Jirku˚ M, Chocholova´
E, Haralambous C, Pratlong F, Obornı´k M, Hora´k A, Ayala FJ, Miles MA. 2007. Evolutionary and geographical
history of the Leishmania donovani complex with a revision of current taxonomy. Proceedings of the National
Academy of Sciences of the United States of America 104:9375–9380. doi: 10.1073/pnas.0703678104
Lynch M. 2008. Estimation of nucleotide diversity, disequilibrium coefficients, and mutation rates from high-
coverage genome-sequencing projects. Molecular Biology and Evolution 25:2409–2419. doi: 10.1093/molbev/
msn185
Mauricio IL, Yeo M, Baghaei M, Doto D, Pratlong F, Zemanova E, Dedet JP, Lukes J, Miles MA. 2006. Towards
multilocus sequence typing of the Leishmania donovani complex: resolving genotypes and haplotypes for five
polymorphic metabolic enzymes (ASAT, GPI, NH1, NH2, PGD). International Journal for Parasitology 36:757–
769. doi: 10.1016/j.ijpara.2006.03.006
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S,
Hanna M, DePristo MA. 2010. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-
generation DNA sequencing data. Genome Research 20:1297–1303. doi: 10.1101/gr.107524.110
Miotto O, Almagro-Garcia J, Manske M, Macinnis B, Campino S, Rockett KA, Amaratunga C, Lim P, Suon S,
Sreng S, Anderson JM, Duong S, Nguon C, Chuor CM, Saunders D, ManskeSe MY, Lon C, Fukuda MM,
Amenga-Etego L, Hodgson AV, Asoala V, Imwong M, Takala-Harrison S, Nosten F, Su XZ, Ringwald P, Ariey F,
Dolecek C, Hien TT, Boni MF, Thai CQ, Amambua-Ngwa A, Conway DJ, Djimde´ AA, Doumbo OK, Zongo I,
Ouedraogo JB, Alcock D, Drury E, Auburn S, Koch O, Sanders M, Hubbart C, Maslen G, Ruano-Rubio V, Jyothi
D, Miles A, O’Brien J, Gamble C, Oyola SO, Rayner JC, Newbold CI, Berriman M, Spencer CC, McVean G, Day
NP, White NJ, Bethell D, Dondorp AM, Plowe CV, Fairhurst RM, Kwiatkowski DP. 2013. Multiple populations of
artemisinin-resistant Plasmodium falciparum in Cambodia. Nature Genetics 45:648–655. doi: 10.1038/ng.2624
Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, Lim P, Mead D, Oyola SO, Dhorda
M, Imwong M, Woodrow C, Manske M, Stalker J, Drury E, Campino S, Amenga-Etego L, Thanh TN, Tran HT,
Ringwald P, Bethell D, Nosten F, Amato R, Pukrittayakamee S, Chotivanich K, Chuor CM, Nguon C, Suon S,
Sreng S, Newton PN, Mayxay M, Khanthavong M, Hongvanthong B, Htut Y, Han KT, Kyaw MP, Faiz MA,
Fanello CI, Onyamboko M, Mokuolu OA, Jacob CG, Takala-Harrison S, Plowe CV, Day NP, Dondorp AM,
Spencer CC, McVean G, Fairhurst RM, White NJ, Kwiatkowski DP. 2015. Genetic architecture of artemisinin-
resistant Plasmodium falciparum. Nature Genetics 47:226–234. doi: 10.1038/ng.3189
Monte-Neto R, Laffitte MC, Leprohon P, Reis P, Fre´zard F, Ouellette M. 2015. Intrachromosomal amplification,
locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania
(Viannia) guyanensis. PLoS Neglected Tropical Diseases 9:e0003476. doi: 10.1371/journal.pntd.0003476
Moorjani P, Patterson N, Hirschhorn JN, Keinan A, Hao L, Atzmon G, Burns E, Ostrer H, Price AL, Reich D. 2011.
The history of African gene flow into Southern Europeans, Levantines, and Jews. PLoS Genetics 7:e1001373.
doi: 10.1371/journal.pgen.1001373
Mukherjee A, Boisvert S, Monte-Neto RL, Coelho AC, Raymond F, Mukhopadhyay R, Corbeil J, Ouellette M.
2013. Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania. Molecular
Microbiology 88:189–202. doi: 10.1111/mmi.12178
Mukhopadhyay R, Mukherjee S, Mukherjee B, Naskar K, Mondal D, Decuypere S, Ostyn B, Prajapati VK, Sundar
S, Dujardin JC, Roy S. 2011. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical
and biophysical studies and interaction with host cells. International Journal for Parasitology 41:1311–1321.
doi: 10.1016/j.ijpara.2011.07.013
Newby ZE, O’Connell J, Robles-Colmenares Y, Khademi S, Miercke LJ, Stroud RM. 2008. Crystal structure of the
aquaglyceroporin PfAQP from the malarial parasite Plasmodium falciparum. Nature Structural & Molecular
Biology 15:619–625. doi: 10.1038/nsmb.1431
Imamura et al. eLife 2016;5:e12613. DOI: 10.7554/eLife.12613 24 of 39
Research article Epidemiology and global health Microbiology and infectious disease
Ostyn B, Gidwani K, Khanal B, Picado A, Chappuis F, Singh SP, Khanal B, Sundar S, Boelaert M. 2011. Incidence
of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a
prospective study. PLoS Neglected Tropical Diseases 5:e1284. doi: 10.1371/journal.pntd.0001284
Paradis E, Claude J, Strimmer K. 2004. APE: Analyses of Phylogenetics and Evolution in R language.
Bioinformatics 20:289–290.
Patterson N, Moorjani P, Luo Y, Mallick S, Rohland N, Zhan Y, Genschoreck T, Webster T, Reich D. 2012. Ancient
admixture in human history. Genetics 192:1065–1093. doi: 10.1534/genetics.112.145037
Pigott DM, Bhatt S, Golding N, Duda KA, Battle KE, Brady OJ, Messina JP, Balard Y, Bastien P, Pratlong F,
Brownstein JS, Freifeld CC, Mekaru SR, Gething PW, George DB, Myers MF, Reithinger R, Hay SI. 2014. Global
distribution maps of the leishmaniases. eLife 3:e02851. doi: 10.7554/eLife.02851
Plourde M, Ubeda JM, Mandal G, Monte-Neto RL, Mukhopadhyay R, Ouellette M. 2015. Generation of an
aquaglyceroporin AQP1 null mutant in Leishmania major. Molecular and Biochemical Parasitology 201:108–
111. doi: 10.1016/j.molbiopara.2015.07.003
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis
corrects for stratification in genome-wide association studies. Nature Genetics 38:904–909. doi: 10.1038/
ng1847
Pritchard JK, Stephens M, Donnelly P. 2000. Inference of population structure using multilocus genotype data.
Genetics 155:945–959.
Quispe Tintaya KW, Ying X, Dedet JP, Rijal S, De Bolle X, Dujardin JC. 2004. Antigen genes for molecular
epidemiology of leishmaniasis: polymorphism of cysteine proteinase B and surface metalloprotease
glycoprotein 63 in the Leishmania donovani complex. The Journal of Infectious Diseases 189:1035–1043. doi:
10.1086/382049
Reich D, Thangaraj K, Patterson N, Price AL, Singh L. 2009. Reconstructing Indian population history. Nature
461:489–494. doi: 10.1038/nature08365
Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS,
Das ML, RaiKarki KP, Singh R, Boelaert M, Dujardin JC. 2013. Increasing failure of miltefosine in the treatment
of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clinical
Infectious Diseases 56:1530–1538. doi: 10.1093/cid/cit102
Rijal S, Yardley V, Chappuis F, Decuypere S, Khanal B, Singh R, Boelaert M, De Doncker S, Croft S, Dujardin JC.
2007. Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for
prognosis of in vivo therapy outcome? Microbes and Infection 9:529–535. doi: 10.1016/j.micinf.2007.01.009
Rogers MB, Hilley JD, Dickens NJ, Wilkes J, Bates PA, Depledge DP, Harris D, Her Y, Herzyk P, Imamura H, Otto
TD, Sanders M, Seeger K, Dujardin JC, Berriman M, Smith DF, Hertz-Fowler C, Mottram JC. 2011.
Chromosome and gene copy number variation allow major structural change between species and strains of
Leishmania. Genome Research 21:2129–2142. doi: 10.1101/gr.122945.111
Roze D, Michod RE. 2010. Deleterious mutations and selection for sex in finite diploid populations. Genetics
184:1095–1112. doi: 10.1534/genetics.109.108258
Sali A, Blundell TL. 1993. Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular
Biology 234:779–815. doi: 10.1006/jmbi.1993.1626
Scho¨nian G, Mauricio I, Gramiccia M, Can˜avate C, Boelaert M, Dujardin JC. 2008. Leishmaniases in the
Mediterranean in the era of molecular epidemiology. Trends in Parasitology 24:135–142. doi: 10.1016/j.pt.
2007.12.006
Stamatakis A. 2014. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies.
Bioinformatics 30:1312–1313. doi: 10.1093/bioinformatics/btu033
Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population
data. American Journal of Human Genetics 68:978–989. doi: 10.1086/319501
Sundar S, Chakravarty J. 2015. An update on pharmacotherapy for leishmaniasis. Expert Opinion on
Pharmacotherapy 16:237–252. doi: 10.1517/14656566.2015.973850
Sundar S, Singh A, Rai M, Prajapati VK, Singh AK, Ostyn B, Boelaert M, Dujardin JC, Chakravarty J. 2012.
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clinical Infectious
Diseases 55:543–550. doi: 10.1093/cid/cis474
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics
analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Molecular
Biology and Evolution 28:2731–2739. doi: 10.1093/molbev/msr121
Tennessen JA, Bigham AW, O’Connor TD, Fu W, Kenny EE, Gravel S, McGee S, Do R, Liu X, Jun G, Kang HM,
Jordan D, Leal SM, Gabriel S, Rieder MJ, Abecasis G, Altshuler D, Nickerson DA, Boerwinkle E, Sunyaev S,
Bustamante CD, Bamshad MJ, Akey JM, Broad GO, Seattle GO, NHLBI Exome Sequencing Project. 2012.
Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337:
64–69. doi: 10.1126/science.1219240
Thakur CP. 2007. A new strategy for elimination of kala-azar from rural Bihar. The Indian Journal of Medical
Research 126:447–451.
Uzcategui NL, Zhou Y, Figarella K, Ye J, Mukhopadhyay R, Bhattacharjee H. 2008. Alteration in glycerol and
metalloid permeability by a single mutation in the extracellular C-loop of Leishmania major aquaglyceroporin
LmAQP1. Molecular Microbiology 70:1477–1486. doi: 10.1111/j.1365-2958.2008.06494.x
Van Meirvenne N, Janssens PG, Magnus E. 1975. Antigenic variation in syringe passaged populations of
Trypanosoma (Trypanozoon) brucei. 1. Rationalization of the experimental approach. Annales De La Societe
Belge De Medecine Tropicale 55:1–23.
Imamura et al. eLife 2016;5:e12613. DOI: 10.7554/eLife.12613 25 of 39
Research article Epidemiology and global health Microbiology and infectious disease
Vanaerschot M, Decuypere S, Berg M, Roy S, Dujardin JC. 2013. Drug-resistant microorganisms with a higher
fitness – can medicines boost pathogens? Critical Reviews in Microbiology 39:384–394. doi: 10.3109/
1040841X.2012.716818
Weisenfeld NI, Yin S, Sharpe T, Lau B, Hegarty R, Holmes L, Sogoloff B, Tabbaa D, Williams L, Russ C, Nusbaum
C, Lander ES, MacCallum I, Jaffe DB. 2014. Comprehensive variation discovery in single human genomes.
Nature Genetics 46:1350–1355. doi: 10.1038/ng.3121
Wiese M. 1998. A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for
parasite survival in the infected host. The EMBO Journal 17:2619–2628. doi: 10.1093/emboj/17.9.2619
Zhang WW, Ramasamy G, McCall LI, Haydock A, Ranasinghe S, Abeygunasekara P, Sirimanna G,
Wickremasinghe R, Myler P, Matlashewski G. 2014. Genetic analysis of Leishmania donovani tropism using a
naturally attenuated cutaneous strain. PLoS Pathogens 10:e1004244. doi: 10.1371/journal.ppat.1004244
Imamura et al. eLife 2016;5:e12613. DOI: 10.7554/eLife.12613 26 of 39
Research article Epidemiology and global health Microbiology and infectious disease
Appendix 1 - SNP detection procedure using the COCALL
algorithm
1 Consensus variant discovery to reduce tool-specific bias
COCALL (COnsensus of SNP CALL) was designed to overcome a lack of verified SNPs for L.
donovani by combining SNP information from different SNP callers using a consensus calling
scheme based on the framework outlined for the 1000 Genomes project (1000 Genomes
Project et al., 2012). The main premise was that no SNP caller was a priori superior, and that
errors among calling tools tended to differ across sites, whereas true variants showed a
concordant signal. This approach avoided systematic errors unique to each individual SNP
caller by examining their consistency and identifying discordant mutations symptomatic of
false positives (Weisenfeld et al., 2014). These disparities among callers arise from their
differing strategies for tackling repetitive regions, ambiguous read mapping probabilities and
alignments, low complexity regions, tandem repeats, inversions, translocations and regions in
which genuine repeats are collapsed in the reference assembly. By combining this with
population-level information to scale the prior probability of a mutation existing at a known
SNP site, COCALL is optimised for variant discovery in a largely unknown population. This
integrated variant discovery scheme inferred sample genotypes both dependently and
independently of other samples, which may mitigate bias in rare variant discovery: dependent
approaches miss true SNPs and independent ones include many false positives (Han et al.,
2014). COCALL was particularly effective when samples were genetically homogenous and the
sequence quality and read depth among samples was uniform, as in this study. When these
conditions were not met, COCALL was less effective, and population-based methods
implemented in GATK, Freebayes or Samtools Mpileup performed better because these
methods identified base variations based on aggregated depth across the population, and
were less affected by lower quality sequence runs. Computational time for running COCALL
may become prohibitively long for samples with high genetic diversity.
This scheme applied five different mutation detection approaches and computed the support
for each base variation. COCALL interpreted the results of FreeBayes v0.9.5 (Garrison and
Marth, 2012), GATK 2.0-38 (McKenna et al., 2010), Samtools Pileup v0.1.16 (Li et al., 2009)
and Samtools Mpileup v0.1.18 based on reads mapped with Smalt v5.7, and also Cortex
v1.0.5.13 (Iqbal et al., 2012) based on its own assembly and mapping (Figure 2—figure
supplement 1).
2 Attributes of SNP callers used by COCALL
1) Cortex was used as a de novo assembly haplotype-based SNP caller and offered an
independent assessment of SNPs because it did not rely on read alignment and mapping by
Smalt. For SNP calling, we merged SNPs with scores 2.5 identified on the current reference
with de Bruijn graphs with k-mers of 31 and 63 bases; the latter were structurally more
accurate at a cost of nucleotide level accuracy (Iqbal et al., 2012). This approach detected
fewer SNPs overall than other methods, as expected (Weisenfeld et al., 2014). Cortex
depended on de novo assemblies, so its accuracy was lower for repetitive regions and
collapsed repeats. Cortex did not provide strand bias information, so the strand bias of Cortex
SNPs was calculated from based on corresponding strand information from Pileup.
2) Freebayes applied a Bayesian strategy for SNP calling and was used to discover potential
SNPs with SNP scores 50 using default parameters for strand bias and read depth. Unlike
other SNP callers, it detected variation based on the local haplotype across the read length,
and so was superior for variant calling at regions with short repeats. It required disomic
chromosomes: but for this study this limitation did not affect SNP calling because no strict
additional parameters for SNP calling were applied to allow it identify rare variants.
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3) GATK provided two SNP calling methods: one for individual samples, and one based on a
population of related samples (GATK population caller). A SNP score threshold >50 was used
for both. For our sample set, GATK had comparatively lower power to find SNPs at duplicated
loci, and the base quality recalibration (BQR) scheme (DePristo et al., 2011) was not
applicable due to the low number of known SNPs for training and the low total number of
high-frequency candidate SNPs.
4) Samtools Mpileup was applied with a SNP score 20, and called fewer SNPs near indels
compared to GATK and Freebayes. It assumed disomy, inferred SNPs across a population of
samples, and ultimately had a lower false positive rate.
5) Samtools Pileup had a lower SNP detection power at regions with low read coverage, at
gaps, and near indels. However, Pileup was more accurate at high-coverage regions with
lower mapping quality and produced fewer false positives. Here, it was used for candidate
SNPs with a base quality >20 and >10% of reads supporting a SNP being on both the forward
and reverse strands to reduce strand bias which was calculated based on pileup read depth.
11.5% of all candidate SNPs had significant strand bias such that the proportion of either
forward or reverse reads was >90%, and 4% had reads only for forward or for reverse strands.
3 Screening and consensus SNP calling in populations
Candidate SNPs with mapping qualities of 40 across all five callers were retained:
approximately 52% of candidate SNPs were excluded due to low base, SNP or mapping
quality values. SNPs at sites with normalised read depth 0.5 or depth 1.75 or with multiple
derived alleles across the five callers were excluded. 1.75 was used as the upper read depth
limit instead of 2.0, which is often usedas a criterion for duplication, because SNP callers
estimated read depth based on base and mapping quality, so even true duplicated regions
tended to have depth <2.0. In addition, SNPs present in clusters of more than three per seven
bp window were removed as likely to be associated with tandem repeats, small indels and
other sequence artefacts. The modal read depth coverage for each candidate SNP site across
the core population was 49-fold, and the minimum modal read depth in any of the core
population was 14-fold: 1,986,930 genotypes were computed in total.
A panel of 90 sequencing libraries from each of three well-characterised isolates (BPK282,
BPK275 and BPK087) representing three major groups from our core population that were
generated as part of this study were used to calibrate the SNP calling across the population.
The metric of the mean number of callers per candidate SNP site was determined for the
entire set of 300 libraries. Candidate SNP sites in lower complexity regions were accepted
when the mean number of callers 3.5; those in non-masked regions were kept where the
mean number of callers 2.5 (Table A1.1); those in hard-masked regions were omitted. These
criteria resulted in a SNP set supported by a mean of 4.5 callers per SNP. An additional
screening condition on the sum of the individual SNP caller score (>380) was applied to some
lower quality runs (for isolates BHU569A1, BHU572A1, BHU574A1, BHU575A1, BHU581A1,
BHU592A1, BHU741A1, BHU764A1, BHU770A1, BHU777A1, BHU782A1, BHU814A1,
BPK031A1, BPK091A1, BPK157A1, BPK164A1, BPK406A1 and BPK512A1).
Table A1.1. Number of putative SNPs detected by different numbers of SNP calling tools. A
threshold mean number of callers 3 was used, which was elevated to 4 at soft-masked
regions.
#SNP callers Count Cumulative count Freq Cumulative Freq
1 32,072 32,072 0.822 0.822
1.4 154 34,475 0.004 0.884
1.5 498 34,973 0.013 0.896
Table A1.1 continued on next page
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Table A1.1 continued
#SNP callers Count Cumulative count Freq Cumulative Freq
2 965 36,160 0.025 0.927
2.5 38 36,244 0.001 0.929
3 476 36,757 0.012 0.942
3.5 114 36,935 0.003 0.947
4 1,019 38,046 0.026 0.975
4.5 179 38,347 0.005 0.983
5 438 39,015 0.011 1
DOI: 10.7554/eLife.12613.019
The variant read allele frequency, read depth and sum of weighted SNP scores were
measured for each putative SNP to evaluate SNP quality. While false positive SNPs would be
expected to occur more frequently in clusters due to local structural variations or repetitive
sequences: mean distance between COCALL SNPs was approximately equal between
regions of the genome. Allele frequencies inferred from our genotype calls were highly
correlated for the 2418 heterozygous SNPs (r2=0.999) with those derived from frequencies of
reads with each allele for the 191 core isolates. The heterozygous allele read depth
distributions indicated some deviations from the expected value of 0.5 due to a mix of
strand bias, chromosome copy number variation, and variation in read mapping and
alignment. However, few SNPs were heterozygous and few genotypes were ambiguous:
14,825 mutations had read depth allele frequencies of 0.95 or greater.
4 Verification of variants called in individual libraries
We validated 15 true heterozygous SNPs in the reference BPK292/0cl4 isolate by manually
inspecting mapped reads for this isolate, and confirmed that COCALL correctly called these
sites. In addition, we examined variant calls on two isolates (BPK519/12 and BPK156/0; ISC1)
where chromosome 17 is inferred to be monosomic. The mean derived allele frequency at
variant sites on these chromosomes was 99.3% (at 1338 SNPs in BPK519/12) and 99.9% (at
1336 SNPs in BPK156/0). On this chromosome, COCALL called 1337 homozygous SNPs and
a single heterozygous one for BPK519/12 and 1318 homozygous SNPs and 18 heterozygous
ones for BPK156/0. While eliminating all heterozygous calls may seem optimal, it was
possible that some cells were not monosomic for this chromosome, and choosing
parameters that eliminated all heterozygous SNP calls removed many valid homozygous
ones
Imamura et al. eLife 2016;5:e12613. DOI: 10.7554/eLife.12613 29 of 39
Research article Epidemiology and global health Microbiology and infectious disease
5 Comparison of COCALL with GATK population calling
We tested the relative rate of true and false SNP sites and individual genotypes for COCALL
and population-based GATK (DePristo et al., 2011) using read data of three previously
studied isolates (Downing et al., 2011) (BPK282/0cl4, BPK087/0cl11, BPK275/0cl18,
sampled from the most frequent genetic populations ISC4, ISC5 and ISC6 respectively). We
created artificial pairwise mixes of these samples in proportions of 1:9, 2:8, 3:7, 4:6, 5:5, 6:4,
7:3, 8:2, 9:1 and unmixed, with depth levels adjusted for the relative proportions of
unmapped reads in each. With these data, COCALL identified more rare variant SNPs in
mixed libraries for the BPK275/0cl18-BPK087/0cl11 mix (Table A1.2). BPK282/0cl4 was the
reference genome strain and so should possess only heterozygous SNPs, and so its variant
discovery rate was substantially lower when combined in mixed libraries. Consequently, for
the mixed libraries of BPK282/0cl4-BPK087/0cl11 and BPK282/0cl4-BPK275/0cl18, once the
fraction of non-reference reads <30%, the sensitivity of COCALL was superior to that for the
GATK population caller.
Table A1.2. The fraction of discordant true and false SNPs between COCALL and GATK
population-based variant calling. COCALL had a greater proportion of true SNPs – confirmed
by visual inspection of mapping reads – both in terms of the number of variant sites, and across
the population of samples.
SNP caller
Sites Mutations
True False True False
COCALL 106 33 991 118
76.3% 23.7% 89.4% 10.6%
GATK population caller 33 106 118 991
23.7% 76.3% 10.6% 89.4%
DOI: 10.7554/eLife.12613.020
Specifically, the population-based GATK and COCALL both called 11,389 variant genotypes
in the artficially mixed samples, while GATK called 718 SNPs not detected using COCALL,
and COCALL found 396 additional SNPs not in the GATK set: a total of 1109 discordant
variants at 139 sites. Visual inspection of mapped reads using Artemis (Carver et al., 2008)
and Samtools tview (Li et al., 2009) indicated that 89% (354) of these 396 unique to
COCALL were valid. COCALL had a greater proportion of true SNPs both in terms of the
number of variant sites, and across the population of samples. This illustrated COCALL’s
improved power for detecting variants at novel sites, compared with GATK (Table A1.3).
Table A1.3. The rate of SNP calling for different combinations of read libraries of samples
BPK282/0cl4, BPK087/0cl11 and BPK275/0cl18. BPK282/0cl4 was the reference genome strain
and so should possess only heterozygous SNPs, and so its variant discovery rate was
substantially lower. COCALL identified more rare variant SNPs in mixed libraries.
Read library combinations
Unique to COCALL Shared
Unique to GATK
population callerBPK282/0cl4 BPK275/0cl18 BPK087/0cl11
89% 11% 14 140 6
80% 20% 7 182 7
70% 30% 6 191 7
60% 40% 9 193 7
50% 50% 7 194 7
40% 60% 5 196 6
30% 70% 7 191 6
20% 80% 7 178 8
11% 89% 9 145 6
89% 11% 10 50 5
Table A1.3 continued on next page
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Table A1.3 continued
Read library combinations
Unique to COCALL Shared
Unique to GATK
population callerBPK282/0cl4 BPK275/0cl18 BPK087/0cl11
80% 20% 11 112 5
70% 30% 5 129 4
60% 40% 7 131 5
50% 50% 7 131 6
40% 60% 6 132 6
30% 70% 5 133 6
20% 80% 4 130 6
11% 89% 4 127 6
89% 11% 15 64 3
80% 20% 14 107 4
70% 30% 4 129 3
60% 40% 4 132 3
50% 50% 3 133 4
40% 60% 3 132 5
30% 70% 4 131 4
20% 80% 3 130 5
11% 89% 3 126 6
DOI: 10.7554/eLife.12613.021
COCALL discovered a total of 2418 SNPs (4.3% of the original candidate set) in the 191
isolates from the core population. We calculated that our calling approach had a 99% chance
of finding variants segregating at a frequency 0.024 in the Core 191 and 0.173 in ISC1
(Table A1.4).
Table A1.4. The probabilities of observing alleles at a specific frequency in the core population
and ISC1. We assessed whether or not the SNPs we discovered in our sample of ISC L.
donovani were likely to be representative of the variation existing in the wider population of
parasites circulating in the ISC. We first assessed the chance of discovering alleles at frequency
f as 1-(1-f)^2n in the core population (n=191) and ISC1 (n=12) sample sets (Gutenkunst et al.,
2009). As a second approach, we evaluated the chance of sampling at least one derived allele
in n sampled chromosomes (as above) assuming these come from a population of size N=1000
following a hypergeometric distribution (Tennessen et al., 2012). Both approaches confirm we
have good power (>99% probability) of sampling alleles with population frequencies as low as
1.2% in the core population, but are likely to miss many variants in ISC1.
Allele Frequency
P(derived allele)=1-(1-f)2n
M
0
 
N  M
n
 
=
N
n
 
P(derived allele)=1 –
Core population ISC1 Core population ISC1
0.001 0.318 0.024 0.382 0.024
0.002 0.535 0.047 0.618 0.047
0.003 0.683 0.07 0.91 0.07
0.004 0.784 0.092 0.945 0.092
0.005 0.853 0.113 0.966 0.115
0.006 0.9 0.134 0.979 0.136
Table A1.4 continued on next page
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Table A1.4 continued
Allele Frequency
P(derived allele)=1-(1-f)2n
M
0
 
N  M
n
 
=
N
n
 
P(derived allele)=1 –
Core population ISC1 Core population ISC1
0.007 0.932 0.155 0.987 0.157
0.008 0.953 0.175 0.992 0.177
0.009 0.968 0.195 0.997 0.197
0.01 0.978 0.214 0.999 0.217
0.012 0.99 0.252 0.999 0.254
0.015 0.997 0.304 0.999 0.307
0.021 0.999 0.399 0.999 0.403
0.024 0.999 0.442 1 0.446
0.029 0.999 0.507 1 0.511
0.038 0.999 0.605 1 0.61
0.039 0.999 0.615 1 0.619
0.04 1 0.625 1 0.629
0.049 1 0.701 1 0.705
0.065 1 0.801 1 0.805
0.092 1 0.901 1 0.904
0.173 1 0.99 1 0.99
0.272 1 1 1 1
DOI: 10.7554/eLife.12613.022
6 Singleton SNPs and transition-transversion ratios
Singleton SNP calls (those called in only a single isolate) are expected to be more error-prone
than shared variants (Han et al., 2014). We examined the fractions of pairs of singletons;
doubletons (SNPs observed in two samples); and all other SNPs (3 samples) that co-occur
within blocks of a range of sizes (10 b, 100 b, 500 b, 1 kb, 5 kb, 10 kb, 50 kb, 100 kb, 500 kb,
1 Mb, 5 Mb) to evaluate evidence of clustering: erroneous regions tend to have SNPs
clustered together, and so more pairs of SNPs will co-occur within small blocks. We see this
effect in SNP calls from Samtools Pileup (Table A1.5) but not for other callers or in the
COCALL consensus. No difference between rates of SNPs called at coding and non-coding
regions were observed. Very few sites were called as having more than two alleles
(Supplementary file 2, table t).
Table A1.5. The percentage of SNP pairs for all pairs on the same chromosome for which both
SNPs occur within a block, for different block sizes (kb) for Cortex, GATK, Samtools Mpileup
and Pileup (Supplementary Table 6). Singletons may have clustered for Samtools Pileup, but
not for Cortex, GATK or Samtools Mpileup. The mean distance was calculated the average
distance between SNPs of the given type on the same chromosome. Non-rare SNPs were those
found in three or more samples.
SNP Caller SNP type
Block size (kb)
0.01 0.1 0.5 1 5 10 50 100 500
Table A1.5 continued on next page
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Table A1.5 continued
SNP Caller SNP type
Block size (kb)
0.01 0.1 0.5 1 5 10 50 100 500
Cortex Non-rare 0.0 0.3 0.9 1.1 1.7 3.4 9.6 17.0 61.5
Doubletons 1.5 1.5 1.5 1.5 3.1 3.1 10.8 13.8 64.6
Singletons 0.0 0.0 0.0 0.0 3.8 3.8 23.1 30.8 80.8
All 0.0 0.3 0.9 1.1 1.7 3.3 9.6 17.0 61.5
GATK Non-rare 0.0 0.1 0.2 0.3 1.1 2.1 9.3 17.8 64.4
Doubletons 1.3 1.3 1.3 1.3 1.3 1.3 5.3 13.3 61.3
Singletons 0.0 0.0 0.0 0.0 1.1 3.2 11.8 18.3 77.4
All 0.0 0.1 0.2 0.3 1.1 2.1 9.3 17.8 64.4
Samtools Mpileup Non-rare 0.0 0.1 0.3 0.4 1.2 2.2 9.5 17.9 64.4
Doubletons 0.0 0.0 0.0 0.0 6.7 6.7 6.7 20.0 60.0
Singletons 0.0 0.0 0.0 0.0 9.1 9.1 9.1 9.1 81.8
All 0.0 0.1 0.3 0.4 1.2 2.2 9.5 17.9 64.4
Samtools Pileup Non-rare 0.0 0.1 0.2 0.3 1.1 2.1 9.3 17.8 64.4
Doubletons 2.6 3.3 3.3 3.3 5.3 6.6 11.8 21.1 63.2
Singletons 0.8 4.4 5.2 5.2 5.7 6.3 13.4 24.9 71.6
All 0.0 0.1 0.2 0.3 1.1 2.1 9.3 17.8 64.5
DOI: 10.7554/eLife.12613.023
We also looked at the transition/transversion (Ti/Tv) ratio, as transitions are expected
biologically to be more common than transversions, while random (noisy) SNP calls will have
Ti/Tv close to 0.5, as there are 4 possible transition mutations and 8 transversions. We
calculated Ti/Tv ratios for variants in the core population of 191 (plus one additional closely
related sample, BHU1087/0). We find that SNP calls supported by multiple callers had higher
Ti/Tv ratios (Table A1.6), with the highest ratio for SNPs called by all five callers (2.74). Ti/Tv
ratios consistently differed between singletons, doubletons and non-rare variants regardless
of SNP caller: for SNPs called by all five methods, non-rare variants had higher rates (Ti/
Tv=7267/1914=3.80) than doubletons (558/298=1.87) or singletons (1316/1124=1.17), as
expected if singleton variants are more likely to be false positives. Ti/Tv ratios of non-rare
SNPs were much higher than singleton SNPs across SNP sets called by Cortex-Mpileup (3.61
vs 0.91), Cortex-Pileup (3.08 vs 0.79), Cortex-GATK (2.26 vs 0.53), and Cortex-Freebayes
(1.51 vs 0.40). While non-protozoan inter-species comparisons find a Ti/Tv ratio of 2.0–2.1 for
genome-wide datasets and 3.0–3.3 for coding SNPs (Ebersberger et al., 2002;
Freudenberg-Hua et al., 2003), we find higher Ti/Tv ratios at non-coding regions than
coding regions, irrespective of SNP caller(s) used. Moreover, this effect was higher for high-
confidence SNPs such as those called by all five callers and those present in multiple isolates.
For example, for SNPs called by all five calling tools, all variants: coding Ti/Tv=4154/
1736=2.39 vs non-coding 4987/1600=3.12; non-rare SNPs: coding 3285/1033=3.18 vs non-
coding 3982/881=4.52; singleton SNPs: coding 617/565=1.09 vs non-coding 699/559=1.15.
Table A1.6. The transition (Ti) and transversion (Tv) mutation rates and Ti/Tv ratio across five
SNP callers (Cortex, Freebayes, GATK, Samtools Mpileup, Samtools Pileup). SNP sets were
selected from the intersection of the SNP calling methods marked X on the corresponding
columns (for example, the first row uses the intersection of SNPs called by all five methods).
The independent genome assembly and haplotype-based variant calling scheme utilised by
Cortex complemented other calling methods based on Smalt assemblies well, based on the
increase of the Ti/Tv ratio.
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Cortex Freebayes GATK Samtools mpileup Samtools pileup Ti Tv Ti/Tv
X X X X X 9141 3336 2.74
X X X X 9229 3411 2.71
X X X X 9150 3418 2.68
X X X 9239 3499 2.64
X X X X 9323 3832 2.43
X X X 9418 3951 2.38
X X X 9339 3960 2.36
X X 9436 4127 2.29
X X X X 9194 4426 2.08
X X X 9221 4591 2.01
X X X 9289 4628 2.01
X X 9342 4841 1.93
X X X 9507 6899 1.38
X X 9642 7536 1.28
X X 10,399 13,101 0.79
X 13,351 28,388 0.47
X 1,904,004 3,340,432 0.57
X 152226 553,889 0.27
X 41,107 137,315 0.30
X 42,902 153,295 0.28
DOI: 10.7554/eLife.12613.024
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Appendix 2 - Somy, CNV, indel and episome detection
1 Chromosome copy number estimation
The reads mapped by Smalt v5.7 were used to estimate the read depth for each sample at each
chromosome and region using the coverage values from Samtools v0.1.18. Chromosomal read
depths were computed from the median read depth for sites with depths within one standard
deviation of the initial estimate of the depth for each chromosome, and normalised as the
depth per haploid genome as outlined previously (Downing et al., 2011). The genome-wide
values per sample allowed the assignment of monosomic, disomic, trisomic, tetrasomic,
pentasomic and hexasomic chromosomes as continuous values to allow for intra-sample
variation in somy among cells. Where the most frequent somy was trisomy rather than disomy,
then chromosome copy number was normalised to reflect that trisomy was the median
chromosome read depth of a given strain. The range of monosomy, disomy, trisomy,
tetrasomy and pentasomy was defined to be the haploid normalized chromosome depth dch
of dch < 0.65, 0.65  dch < 1.25, 1.25  dch < 1.75, 1.75  dch < 2.25 and 2.25  dch < 2.75
(Table A2.1).
Table A2.1. Somy status of 36 chromosomes in 206 strains (204 with JPCM5 and LV9). The range
of monosomy, disomy, trisomy, tetrasomy and pentasomy was defined to be the haploid
normalized chromosome depth dch of dch < 0.65, 0.65  dch < 1.25, 1.25  dch < 1.75, 1.75  dch
< 2.25 and 2.25  dch < 2.75.
Count Percentage
Monosomy 2 0.03
Disomy 5851 78.90
Trisomy 1229 16.57
Tetrasomy 310 4.18
Pentasomy 24 0.32
DOI: 10.7554/eLife.12613.025
2 Copy number variation
Baseline coverage levels were established using median depth of over 60 strains among ISC4,
ISC6, ISC7 and ISC8 so that potential CNVs were determined in comparison to the haploid
normalised depth. For CNV detection, we also considered CNV length along with depth
because long heterozygous deletions or duplications were observed that could be reliably
identified at lower depth than shorter variants. Therefore we used three different depth
thresholds: for CNVs of 2 to 5 kb, the threshold was five times the standard deviation of the
chromosomal depth; for CNVs of 5 to 20 kb, the threshold was three times this value; for
CNVs of >20 kb, the threshold was 1.5 times this value.
Adjacent CNV pairs in individual samples were combined when two nearby CNVs were
located within 1/3 of the length of the longer of the two CNVs, because two independent
adjacent CNVs would be a less parsimonious pattern. When a CNV pairwise distance was
calculated, common boundaries of a given CNV among the samples were assigned to
include every start and end of the CNV of each strain, and then the depth was calculated for
each CNV range. Boundaries of CNVs were manually checked and CNVs overlapping large
gaps were excluded. Candidate CNVs in the first 300 bp and last 5 Kb of all chromosomes
were excluded. Adjacent CNVs were merged if the inter-CNV gap was smaller than the
average length of the flanking CNVs.
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3 Insertion and deletion discovery
Small indels, less than 10 bp, were detected by a four-caller method (Freebayes, GATK,
Samtools Mpileup, Cortex). Pileup was not used because its indel detection method was not
sufficiently powerful. The indel calling scheme was analogous to COCALL except that indels
identified by at least three methods were accepted (instead of 2.5). To count allele frequency
of indels at AQP1 more precisely, we used Smalt v7.1 that can map reads around indels
more accurately by locating indels at the same base position for both forward and reverse
strands. The AQP1 indel at 7,739 on chromosome 31 was visually inspected for all the strains
using IGV and Samtools tview.
4 MAPK1 and H-locus amplicon detection
Read depth coverage was used to identify potential extra- or intra-chromosomal gene
amplifications where levels were significantly elevated over an extended 10–50 Kb regions
flanked by repetitive segments. Two of these variants: the copy number variation of the
MAPK1 and H-locus amplicons was verified in a qPCR assay (SensiMix SYBR No-ROX, Bioline)
performed on the LightCycler 480 (Roche Life Science). The genes MRPA (forward 5’-
TGTGTTTCCGACGATTGC-3’, reverse 5’-GTGACCCGCTTTGTGGAC-3’) and MAPK1
(forward 5’-GTGGTCGCGCTGCAGAAG-3’, reverse 5’-CGGCACAACCCCTTCATTG-3’) were
targeted in a subset of 46 samples. Cysteine synthase (LdBPK_363750) was used as a
reference gene (forward 5’-GTCTTGGCGGTTCAGTTCG-3’, reverse 5’-
GACATTGTGGTTCGTCTGCTC-3’), and BPK026/0cl5 was used for normalization of copy
numbers. This strain has three and two chromosomal copies of the H-locus and MAPK1,
respectively.
The nature of the amplification (extra- or intra-chromosomal) was determined by pulsed-field
gel electrophoresis (PFGE) and southern blot hybridization. Intact chromosomes were
prepared from logarithmic phase cultures of Leishmania promastigotes and separated by
PFGE using a Bio-Rad CHEF-Mapper XA at 6V/cm, 120˚ separation angle and a range of
separation from 100 kb to 2.5 Mb. Gels were transferred by capillarity and hybridized with
[a-32P]dCTP-labelled DNA probes specific for MAPK1, HTBF (H-locus) or LinJ35.4130
(LdBPK_354130), according to standard protocols.
To exclude the possibility that the amplicons are a culturing artefact, a PCR using primers
that enable amplification on circular episomes or tandem duplications was also attempted
directly on five bone marrow samples from VL patients. The edges of the chromosomal loci
that code for the MAPK1 and DHFR-TS genes are targeted with primers (MAPK1: forward 5’-
CATGGCGCAGTGACCTTCAG-3’, reverse 5’-TCTTGGCACGGCATCAGCAG-3’; DHFR-TS:
forward 5’-CCTACCCGCTTGCTTGCTTG-3’, reverse 5’- CAGCAGCACAATGGAAAGAACG-
3’).
5 Correlation between SNPs, CNVs, indels and somy
variation
The correlation coefficients of pairwise distances between samples based on SNP, CNV, indel
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and somy diversity were calculated. Some strains were clearly phylogenetically related, so
correlation between these values was expected simply due to the phylogenetic structure of
our samples. To alleviate this potential bias, we used Pearson’s correlation for sets of
samples with different degrees of similarity based on SNP pairwise distance. The correlation
coefficients of SNPs with indels and CNVs with SNPs were consistently large in all sample
sets (Table A2.2).
Table A2.2. Pearson’s correlation (r2) between SNP, CNV, indels and somy diversity. The
dependency of the correlation on the normalised pairwise distance is shown: this was
determined from the median normalised pairwise distance based on SNP data. The Mantel
correlation tests showed values that were consistent with the correlations.
Type #samples Normalised pairwise distance threshold Correlation (r2) P value
SNP-INDEL 191 0 0.433 0.00E+00
57 0.15 0.301 2.91E-254
33 0.3 0.271 8.23E-77
191 Mantel test 0.420 0.001
PLO-SNP 191 0 0.073 0.00E+00
57 0.15 0.152 2.69E-118
33 0.3 0.304 9.62E-88
191 Mantel test 0.060 0.001
PLO-INDEL 191 0 0.024 3.88E-197
57 0.15 0.040 2.43E-30
33 0.3 0.072 1.96E-19
191 Mantel test 0.016 0.001
CNV-SNP 191 0 0.289 0.00E+00
57 0.15 0.263 7.53E-218
33 0.3 0.393 4.52E-120
191 Mantel test 0.272 0.001
CNV-PLO 191 0 0.121 0.00E+00
57 0.15 0.150 1.96E-116
33 0.3 0.183 1.59E-49
191 Mantel test 0.103 0.001
CNV-INDEL 191 0 0.099 0.00E+00
57 0.15 0.087 2.34E-66
33 0.3 0.108 1.04E-28
191 Mantel test 0.084 0.001
DOI: 10.7554/eLife.12613.026
Correlations of our values with somy were more variable, probably because somy was more
prone to homoplasy as it appears to mutate faster than other genetic variants in this study
(Table A2.2). Spearman’s rank correlations were also calculated and showed a similar level of
correlation (data not shown). We also used Mantel tests to directly test correlation between
the full matrices of pairwise distances. The results of Mantel tests were in concordance with
Pearson’s correlation values. Pearson’s and Spearman’s correlations were calculated using
python-stats-0.6 (Gary Strangman http://sourcecodebrowser.com/python-stats/0.6/stats_8py.
html). Mantel tests were implemented in R package vegan (https://github.com/vegandevs/
vegan).
Imamura et al. eLife 2016;5:e12613. DOI: 10.7554/eLife.12613 37 of 39
Research article Epidemiology and global health Microbiology and infectious disease
6 Correlation between duplicated genes and somy
variation
Information on duplicated genes in the reference genome was based on multi-copy gene
families annotated in the L. infantum JPCM5 reference genome (Table A2.3) (Rogers et al.,
2011). In the present study, each read was mapped to its most similar region in the
reference, and where reads could be mapped with equal mapping scores to multiple
locations, one position was selected randomly to quantify read depth, in contrast to the
previous study in which read depth was under-estimated by only using uniquely-mapped
reads (Rogers et al., 2011). A threshold of 1.5 times the haploid depth was used to identify
duplicated genes (a more conservative threshold of 2.0 did not change results materially).
This threshold of 1.5 was effective for Illumina Hiseq data, where fluctuations in read depth
were smaller than those previously seen using the Illumina Genome Analyser II. To illustrate
this, the normalised standard deviation (standard deviation divided by average chromosome
depth) of 17 strains sequenced by Genome Analyser II in was 0.32 (Downing et al., 2011),
and in the current analysis, using Illumina Hiseq 2000 data, this was 0.19. We were therefore
able to quantify more subtle depth variation than previous analyses. To normalise for
differences in chromosome lengths, the number of duplicated genes was expressed per unit
chromosome with a length set to that of chromosome 1. Results from between-species
analysis (Rogers et al., 2011) have previously suggested a link between somy variation and
copy number variation. However, in the present study, the correlation of duplicated genes
per chromosome with the somy level was statistically significant but the effect size was very
small (n=7146 chromosomes, r2=0.027, p=7.03x10-46), suggesting no relationship or only a
weak one, between somy level and copy number at the population level.
Table A2.3. Correlation between CNV and ploidy of chromosomes in 206 strains: the
duplication threshold was 0.5. p values <0.02 were observed for chromosomes 1, 2, 3, 17, 19,
20, 21 and the whole genome.
Correlation (r2) P value
chromosome 0.027 7.03E-46
1 0.039 4.23E-03
2 0.202 1.21E-11
3 0.074 7.81E-05
4 0.003 4.31E-01
5 0 9.30E-01
6 0.004 3.86E-01
7 0.003 4.68E-01
8 0.001 6.05E-01
9 0.001 7.32E-01
10 0.015 7.77E-02
11 0.002 4.88E-01
12 0.005 3.16E-01
13 0.001 6.57E-01
14 0.001 7.31E-01
15 0.001 7.42E-01
16 0.009 1.81E-01
17 0.036 6.06E-03
18 0.005 3.23E-01
19 0.077 5.41E-05
20 0.064 2.51E-04
Table A2.3 continued on next page
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Table A2.3 continued
Correlation (r2) P value
21 0.027 1.87E-02
22 0.009 1.87E-01
23 0.007 2.42E-01
24 0 9.68E-01
25 0.009 1.87E-01
26 0.017 5.97E-02
27 0.009 1.85E-01
28 0.001 6.80E-01
29 0.009 1.67E-01
30 0.003 4.28E-01
31 0.004 3.77E-01
32 0.005 3.28E-01
33 0.011 1.41E-01
34 0.001 7.61E-01
35 0.011 1.35E-01
36 0.016 7.38E-02
DOI: 10.7554/eLife.12613.027
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